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Abstract
Foetal monitoring during birth is essential to determine foetal well-being through-
out labour. The current method that complements foetal heart rate monitor-
ing, foetal scalp blood sampling for pH determination, is laborious, prone to
errors and invasive. Lactate has been identiﬁed as a potential alternative
measurand for intrapartum foetal monitoring, due to the ability to distin-
guish between diﬀerent types of acidosis. A literature review from the medical
and technical perspective and a patent review were conducted to identify the
current advancements in the ﬁeld of lactate sensing with regards to foetal
monitoring. It was concluded that a less invasive and a continuous monitor-
ing device is required to fulﬁl the clinical needs for intrapartum foetal mon-
itoring. Therefore, a novel biosensor, combining microneedle technology and
electrochemical lactate sensing, was proposed and developed for this purpose.
A fabrication process using the microneedle array was established using an
electron beam evaporator. Commercial screen-printed electrodes were utilised
for the development of an immobilisation protocol exploring covalent bonding
and cross-linking. Electrochemical impedance spectroscopy, cyclic voltamme-
try and amperometry experiments were conducted to assess the success.
A complete microneedle three-electrode prototype sensor was fabricated. The
initial electrochemical analysis of commercially available, screen-printed elec-
trodes concluded that platinum electrodes, in combination with covalent bond-
ing, have the potential to provide the basis for further development towards a
lactate sensor for foetal monitoring during birth.
This work has identiﬁed developmental work required for the immobilisation
process to be able to determine the compatibility with the microneedle array
as an electrode surface.
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1 Introduction
1.1 Motivation
During labour, foetal oxygen supply and carbon dioxide elimination can be
impaired and threaten foetal well-being. Prolonged exposure to decreased gas
exchange means the foetus may become hypoxic or develop acidosis, which can
lead to irreversible damage to its nervous system. The resulting pathologies in-
clude hypoxic ischaemic encephalopathy, cerebral palsy and ultimately foetal
death [1]. Currently, foetal well-being is assessed by monitoring the foetal
heart rate using cardiotocography (CTG). As the CTG has a low true positive
value, leading to unnecessary caesarean sections, non- reassuring heart rate
patterns, indicated by the CTG, are veriﬁed by foetal scalp blood sampling
(FSBS) to determine foetal pH and lactate value [2].
FSBS is an invasive procedure in which a blood sample is obtained from the
unborn foetus, which is accessed through the mother's vagina. The sampled
blood is analysed using a blood gas analyser. Based on the results of the blood
analysis the clinical decision is made as to whether the foetus requires imme-
diate delivery or whether the natural birth process can be continued.
However, FSBS exhibits a number of downsides. Firstly, it can only be per-
formed when the cervix is dilated more than 3 cm. Secondly; the method is
invasive and complex to perform, requiring trained staﬀ [3]. Additionally, the
procedure is lengthy (12-30 mins) [4] and does therefore not provide real-time
or continuous results. The two separate processes of blood sampling and blood
analysis are furthermore susceptible to blood clotting, air bubble (in the cap-
illary tube) and contamination by the amniotic ﬂuid [5]. FSBS also does not
distinguish between foetuses which suﬀer from a temporary oxygen shortage
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and foetuses that suﬀer from a more severe oxygen impairment and require
immediate delivery [6].
Due to the downsides of the current foetal monitoring procedures outlined
above, a more reliable, less invasive and less complex real-time method is re-
searched to enable improved data collection and facilitate the safe delivery of
babies.
1.2 Speciﬁcations
For the development of a new device for foetal monitoring during birth, expert
clinicians dealing regularly with complex labours, Dr. Fiona Denison and
Dr. Sarah Stock, from the Queen's Medical Research Institute (QMRI), have
provided clinical speciﬁcations, which are summarised in this section. Two
measurands, pH and lactate concentration in the foetal blood, are utilised in
FSBS. In order to obtain useful information from the new device, it has to
be able to detect a pH value to two decimal places between 6.50 - 7.50 and
to one decimal place in the ranges of 6 - 6.5 and 7.5 -7 .7. A lactate sensor
would need to provide reliable measurements between 2.0 - 14 mmol/L to one
decimal place. It is required to measure both or either of these measurands
over the whole duration of labour, which can take 12 hours or longer for more
complex labour processes.
Due to the requirements of continuous monitoring, an in-situ sensor that can
be applied to the foetal scalp, is considered to fulﬁl the clinical need.
Additionally, the sensor has to be easy to apply and not cause more trauma
than the current foetal scalp electrode. The sensor also has to conform to the
dimensions of the environment. It has to be able to be applied from cervical
dilation as small as 1 cm and, if a cable is used to transmit the information,
it has to overcome the distance between the foetal scalp to outside the vagina
which is approximately 15-20 cm.
These speciﬁcations form the basis for the development of a foetal monitoring
device during birth.
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1.3 Aims and Objectives
In addition to the speciﬁcation above, a medical and a technical literature
review, with a focus on foetal monitoring and lactate sensing, was conducted.
Based on the speciﬁcations and the literature review a label-free detection
approach, which has been successfully applied in diﬀerent application areas
has been chosen. Therefore, the aim of this research is to design, manufacture
and characterise the performance of an electrochemical based foetal monitoring
system.
Speciﬁc objectives to achieve this goal include:
1. Identiﬁcation and selection of the most appropriate measurand(s).
2. Review of existing electrochemistry based biosensors for the chosen mea-
surand to guide selection of sensing approach, i.e. which type of sensor
and what sort of recognition element.
3. Design and manufacture of an electrode system capable of foetal scalp
integration.
4. Characterisation of immobilisation protocols on diﬀerent electrode sur-
faces.
5. Characterisation of the performance of the resulting system.
1.4 Layout of the thesis
The thesis consists of eight chapters, which are summarised in this section.
Chapter 2 - Fundamentals of Electrochemistry In this chapter a broad
overview about electrochemical sensing and common electrochemical methods
(including cyclic voltammetry and amperometry and basic analyses of the re-
sults) are presented.
Chapter 3 - Literature review: Medical Perspective In this chapter
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background information about the foetal and maternal physiology and current
foetal monitoring procedures are described. Furthermore, potential measur-
ands and bioﬂuids are explored for the development of the foetal monitoring
device.
Chapter 4 - Literature Review: Technical Perspective This chapter
provides a comprehensive review of biosensor focusing on lactate sensing cov-
ering the topics of sampling, recognition, immobilisation, transduction and
sensor materials. Additionally, results of a patent review with regards to foetal
monitoring and lactate/pH sensing are presented.
Chapter 5 - Methods and Results: Sensor Design and Fabrication
In this chapter the design and the fabrication methods and steps are outlined.
The materials and the equipment employed are introduced, which are used to
validate the fabrication methods, develop a mask for electron beam deposition
and to fabricate an adapter.
Chapter 6 - Methods and Results: Immobilisation This chapter pro-
vides the protocols for the covalent bonding and cross-linking immobilisations
methods. Additionally, the results of the characterisation of the success of the
immobilisation are presented.
Chapter 7 - Methods and Results: Amperometric Measurements
This chapter provides the methods and results for the amperometric measure-
ments of the previously functionalised electrodes.
Chapter 8 - Conclusions This chapter concludes the work conducted in the
previous chapters. Furthermore, suggestions for future work for the continuing
development of the foetal monitoring device are given.
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2 Fundamentals of Electrochemistry
The aim of this work is to develop an electrochemical lactate sensor. This chap-
ter therefore provides an overview about the basics of electrochemistry. After
explaining the setup of an electrochemical cell and the processes occurring
upon application of a potential, cyclic voltammetry (CV) and amperometry
measurements are then described.
2.1 General Overview
A biosensor is a sensor in which the sensing is based on a biochemical or
biological reaction. In general, sensing can be divided into two categories;
label-free sensing and labelled sensing; the latter uses an additional reagent
to make the analyte more visible [7]. Label-free sensing holds the following
advantages over labelled sensing [8]:
 Reduction in assay cost
 Reduction of complexity
 Increased amount of quantitative data
 Higher throughput
 Reduced assay development time
 Increased accuracy
As the aim of this project is to develop a lactate sensor for foetal monitoring
during birth, the addition of reagents is to be avoided. For this reason, this
chapter focuses on label-free sensing.
The process of biosensing can be divided into (a) recognition of the analyte
and (b) transduction of the signal, as illustrated in Figure 2.1. The recognition
5
element can be based on enzymes, living cells and aﬃnity interactions. The
choice of the recognition element depends on the application, environment
and the analyte. The signal obtained from the recognition element can be
transduced by thermometric, mechanical, capacitive, electrochemical or optical
means [7].
Figure 2.1: Functionality of biosensors: With the recognition element immobilised
onto the transduction surface to detect an analyte.
The quality of the sensor functionality can be benchmarked by characteristics
such as sensitivity, selectivity, response time and limit of detection. The sensi-
tivity of a sensor is deﬁned as the step change of the output value with regard
to the input value. The selectivity deﬁnes the ability to distinguish between
the measurand of interest and another substance. The time for the sensor to
detect a signal is the response time [9]. The smallest measurand concentration
that is reliably detected is deﬁned as the limit of detection[10].
An electrochemical sensor can have a two-electrode or a three-electrode ar-
rangement (Table 2.1). In a three-electrode system the working electrode
(WE) is the electrode at which the electrochemical reaction of interest oc-
curs. If that reaction is an oxidation, the opposite reaction, a reduction, takes
place at the counter electrode (CE). The third electrode in a three-electrode
system is the reference electrode (RE), which maintains a constant potential.
This is necessary as the potential at the WE must be set to a certain potential
for the chemical reaction to occur. The reference electrode, as the name sug-
gests, acts as a reference point, which is used to set the potential for the WE.
A two-electrode system only has a WE and a CE, which also acts as the RE.
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Table 2.1: Electrodes and their function in an electrochemical cell.
Electrode Function
Working Electrode (WE) Chemical reaction of interest
Counter Electrode (CE) Opposite reaction to WE
Reference Electrode (RE) Provides stable potential for WE.
No current passes through.
As the RE is also the CE, current is passing through the RE, which may alter
the supposedly constant potential of the RE, which subsequently may change
the potential at the WE by the same value, and could compromise the quality
of the results [11].
Figure 2.2 A) presents a schematic drawing of a three-electrode setup con-
nected to a potentiostat [12]. All three electrodes are immersed in the solution
of interest and the potential at the WE is set with regard to the RE. The
resulting current is measured between the WE and the CE. Electronically, the
three-electrode system can be represented by the electrical equivalent circuit
in Figure 2.2 B) [13]. The sensitivity of an electrochemical sensor can be im-
proved with a larger electrode surface area, either by increasing the geometrical
size of the working electrode or by providing a larger electrochemical speciﬁc
surface area. The latter can be obtained by engineering a rougher electrode
surface resulting in a larger surface area. This is the reason for the wide use
of nanomaterials such as nanocubes, nanowires, nano particles and nanotubes
(Section 4.6.5) [14, 15]. Additionally, the speciﬁcity of the sensor can be in-
creased by additionally immobilizing a recognition element on the surface of
the working electrode. The WE will react with the substrate forming species
that will oxidise or reduce at the electrode surface, and change the electronic
parameters (e.g. current, voltage and resistance) by a quantity that depends
on the concentration of the measurand.
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Figure 2.2: A) Schematic drawing of an electrochemical cell connected to a poten-
tiostat [12]. B) Electrical circuit representing an electrochemical cell [13].
Usually, experimental electrochemical reactions take place in a solution, which
is called the supporting electrolyte. It is required that the supporting elec-
trolyte provides a high concentration of inert electrolyte 100 times higher than
the electroactive species of interest. The typical concentration range for a sup-
porting electrolyte is 0.01 M - 1.0 M [16, 17].
When an electrode is immersed in such an electrolyte and a potential is applied
with regards to the reference electrode a double layer is formed, which is a ﬁlm
closest to the electrode surface and it behaves like a capacitor. It can be visu-
alised to be comprised of three layers. The two layers closest to the electrode
which are called the inner and outer Helmholtz plane include ions that balance
out most of the charge. A third layer is the diﬀusion layer which acts as the
connection between the bulk solution and the Helmholtz planes. In general,
the concentration of the electroactive species near the electrode decreases with
time and increases with the distance from the electrode surface.
A simpliﬁed illustration is given in Figure 2.3. The image on the left-hand
side shows the concentration of ions near the electrode surface at the begin-
ning of the measurement and the image on the right presents the situation
after the system has been exposed to a certain potential for a speciﬁc time.
The concentration of the ions near the electrode decreases over time.
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Figure 2.3: Simpliﬁed representation of the double layer and its development over
time with regard to the distance to the electrode surface.
A concentration proﬁle of this development is shown in Figure 2.4.
Figure 2.4: Representation of formation concentration gradient [18].
The composition of the double layer changes with a change in potential [19].
The exchange of electrons and ions due to the oxidation or reduction reactions
facilitates the ﬂow of current. Initially, upon the application of a potential, all
electroactive species close to the electrode surface are oxidised or reduced. As
there is an exchange of electrons during such reactions, this initial depletion is
represented by a current peak in the current vs. time plot. Once the diﬀusion
layer is formed the current is limited by the diﬀusion of the electroactive species
to the electrode surface [11].
The rate of diﬀusion is represented by Fick's ﬁrst law[19]:
J = −DδC
δX
(2.1)
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Where J is the ﬂux of the substance of interest, C is the concentration, D
the diﬀusion coeﬃcient and X the distance from the electrode surface. Both,
the graph and the equation show that the ﬂux decreases with an increasing
distance from the electrode surface [11]. The cell potential is described by the
Nernst equation [19]:
E = EΘ − RT
nF
lnQ (2.2)
Where E is the cell potential, EΘ the standard potential, R the gas constant
(8.314 J/Mol.K), T the temperature in Kelvin, n the number of electrons in-
volved in the chemical redox reaction, F the Faraday constant (96, 485 C/mol)
and Q the reaction quotient (ratio of concentration of the oxidised species ver-
sus the ion concentration of the reduced species). For standard state conditions
at a temperature of 25°C, the Nernst equation can be simpliﬁed to [11]:
E = EΘ − 0.0592
n
lnQ (2.3)
2.2 Cyclic Voltammetry (CV)
Cyclic Voltammetry (CV) is a method used in electrochemistry to study the
thermodynamics and kinetics of an electrochemical system. It can also provide
information about the concentration proﬁle and the potential at which the rate
of reaction is the highest, which is important for amperometric measurements
of an electroactive species as explained in the next section.
In CV, a potential that is swept at a constant rate is applied to the WE relative
to the RE. This results in a current ﬂow due to the oxidation/reduction of the
electroactive species as explained in Section 2.1. An example of the applied
potential waveform is shown in Figure 2.5 (A)). The resulting current is plotted
against the applied potential in a voltammogram (Figure 2.5 B)).
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Figure 2.5: Potential wave applied during cyclic voltammetry (A)) [20]. Typical
cyclic voltammogram with current peaks (B)) [21]. Epc = Cathodic peak voltage, Epa
= Anodic peak voltage, ipc = Cathodic peak current, ipa = Anodic peak current
A cyclic voltammogram (Figure 2.5 B)) consists of a positive and a negative
current response. The peak of the positive current is the oxidation peak and the
peak of the negative current is the reduction peak resulting from the forward
and backward potential sweep applied to the cell, respectively.
The measured current can be further divided into diﬀerent sections. The mea-
surement is started at a potential at which no chemical reaction is expected,
after which the potential is gradually swept further towards the potential at
which the highest rate of reaction takes place. The initial low current measured
is the capacitive current, IC , which represents the charging of the double layer.
The current recorded after the capacitive current is the Faradaic current, If , as
the potential is increased, which represents the onset of the chemical reaction
(oxidation of the analyte). The peaks represent the potential at which the
electrolyte oxidises/reduces the most, producing the highest positive or neg-
ative currents recorded in the voltammogram. Following the oxidation peak
the current decreases despite the increase in potential due to the depletion of
the double layer. Therefore, the total current is [11]:
Itotal = IC + If = Cd
dE
dt
= If = νCd = If (2.4)
The capacitive current (charging of the double layer) acts like a capacitor
changing its charge with increasing potential over time (scan rate ( ν(V/s)
), Cd = capacitance of double layer). A higher scan rate does not allow the
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double layer to reach an equilibrium, meaning that the total current increases
with an increasing scan rate as shown in Figure 2.6.
When sweeping the potential in the opposite direction at the WE, the current
reverses and the species is re-oxidised (re-reduced) until its peak is reached
and the current is again limited by the rate at which the species diﬀuses to the
electrode surface [11].
Figure 2.6: Typical cyclic voltammogram at diﬀerent scan rates [20].
During the analysis of a cyclic voltammogram, the potential diﬀerence related
to the peaks of currents and the ratio of the current peaks are the two main
characteristics that provide information about the reversibility of the reaction
of the electrochemical cell. The peak currents of a voltammogram can be
calculated with utilising the Randle Sevcik equation [22].
I = −2.96 · 105n3/2AD1/2Cν1/2 (2.5)
Where A (cm2) is the electrochemical surface area of the WE, D (cm2/s) the
diﬀusion coeﬃcient of the electroactive species, C (mol/cm3) the concentration
of the electroactive species, ν (V/s) the scan rate and n the number of electrons.
For a reversible system, the separation between the two peaks is 57/n mV (n
= number of electrons) Figure 2.5 B) and the peaks are of the same height
[11].
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|Ep,a − Ep,c| = 57
n
mV (2.6)
∣∣∣∣∣Ip,aIp,c
∣∣∣∣∣ = 1 (2.7)
In sensing applications it is common to only receive one peak because the sub-
stance is only present in one form (reduced or oxidised) and might be broken
down into other substances. This leaves no substances to be re-reduced or
re-oxidised at the electrode surface resulting in no opposite peak when scan-
ning the potential the opposite way. For the development of an amperometric
biosensor, cyclic voltammetry is used to determine the overpotential at which
the amperometric measurements will be performed. The overpotential is the
potential at which the highest current is observed.
2.3 Amperometry
Amperometry is an electrochemical method for the analysis of electrochemical
cell reactions. A potential step, which ranges from -0.2 V to 0.7 V, is applied
to the WE with regard to the RE [23, 24, 25]. A potential electrolysis (re-
duction or oxidation) takes place which is measured as a current over time.
The current response is proportional to the concentration of the analyte being
measured/reduced [19] . For planar electrodes it is described by the Cottrell
equation [26]:
i =
nFAD1/2C
(pit)1/2
(2.8)
Where i is the current response (A), n the number of electrons, F the Faraday
constant, A the electrochemical surface area (cm2), D the diﬀusion coeﬃcient
(cm2/s), C the concentration of the electroactive species (mol/cm3) and t the
time in seconds [11, 18].
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A typical resulting current response is shown in Figure 2.7 right. The current
response represents the reaction to the ﬁrst potential step (Figure 2.7 left).
The spike represents the instantaneous charging of the diﬀusion layer upon
application of the potential step. After this spike, the current decays due to
its dependency on the diﬀusion of the electroactive species to the electrode
surface before plateauing at constant current level [11, 18]. Amperometric
lactate sensors measure the current ﬂow generated by electrons which have
been produced either through the breakdown of H2O2 or NADH. These in-
termediates originate from Lactate oxidase (Lox) and Lactate dehydrogenase
(LDH))(Section 4.3), respectively. The current received upon the application
of the overpotential is equivalent to the concentration of the lactate in the
solution.
Figure 2.7: Potential step for amperometry (left) and the current response (right).
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3 Literature Review:
Medical Perspective
3.1 Introduction
The rationale, which underpins all intrapartum foetal monitoring, is that
timely diagnosis of foetal compromise, may allow treatment by in utero re-
suscitation or delivery before acidaemia, irreversible tissue injury and foetal
death occurs. In the following sections, the circumstances surrounding the foe-
tus during birth and the gas exchanges with the mother, are explained. This
study informs the technologies explored in this thesis. Furthermore, the past
and current foetal monitoring methods and procedures are presented, following
a discussion about potential bioﬂuids for a new foetal monitoring system.
3.2 Foetal-maternal Physiology
The placenta replaces the function of the lungs of the foetus to provide suf-
ﬁcient gas exchange in utero. The foetal heart pumps deoxygenated blood
through the two umbilical arteries to the placenta for the exchange of CO2
and O2. Oxygenated blood is pumped back into the foetal system through the
single umbilical vein. Gas exchange and therefore oxygen supply are depen-
dent on the normal perfusion of the placenta by maternal and foetal blood.
Oxygen provides the basis for energy production from glucose [27]. Uterine
contractions can restrict maternal and foetal blood ﬂow within the placenta
and therefore impair normal gas exchange. Normal contractions are tolerated
well by a healthy foetus via natural compensating mechanisms, due to a gen-
eral oxygen oversupply. If oxygen supply is further restricted, the foetus has
additional methods to preserve perfusion to all vital organs, which include:
15
 Increased extraction of O2 from the maternal blood at the placenta.
 Higher proportion of O2 extracted from the foetal blood by foetal tissue.
 centralisation of blood ﬂow towords vital organs (e.g. brain, heart,
adrenal glands) [28].
Oxygen impairment can endanger growth restricted foetuses more than well-
grown foetuses, due to their diﬀerent compensation capabilities [29]. Failure
to compensate for placental insuﬃciency may cause a prolonged restriction
of foetal gas exchange followed by an increasing lactate concentration and a
decreasing pH value. This process can lead to cell death, threatening foetal
health [27].
Diﬀerent biochemical pathways are followed for energy production when oxy-
gen is present in comparison when it is not, leading to diﬀerent outcomes, as
shown in Figure 3.1.
In the presence of O2 the human body generates energy in form of adenosine
triphosphate (ATP) through glycolysis and the Krebs cycle. However, if the
O2 supply is limited, energy production is made less eﬃcient by the breakdown
of pyruvate by lactate dehydrogenase in the presence of the reduced form of
nicotinamide adenine dinucleotide (NADH) and a H+ ion into lactate and
nicotinamide adenine dinucleotide (NAD+). The NAD+ is vital to maintain a
limited energy production through glycolysis (red arrow in Figure 3.1). The
lactate is broken down into lactic acid and H+ ions causing the pH value to
decrease [30]. When oxygen becomes available again, the fermentation process
is reversed, and lactate dehydrogenase converts lactate back into pyruvate,
which is then used for more eﬃcient energy production in the Krebs cycle
[30, 31, 32]. Whether the energy in the foetus is produced under aerobic or
anaerobic processes depends on the oxygen supplied by the mother.
During the second stage of birth, which is dominated by contractions, the
perfusion in the placenta can be restricted, leading to oxygen deﬁciency [33].
Oxygen deﬁciency can lead to two diﬀerent types of acidosis, respiratory and
metabolic which diﬀer in the source of their development and their impact on
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Figure 3.1: Aerobic and anaerobic metabolisms [32].
the foetus being delivered. In a respiratory acidosis, the H+ ion concentration
increases due to an accumulation of CO2, decreasing the pH. Respiratory aci-
dosis is not a source of long-term neurological consequences, and the foetus
can withstand it with its compensatory methods [1, 27]. Respiratory acidosis
is diagnosed when the pH is lower than 7.36 without the change in base deﬁcit
1(will be explained in Section 3.5.2 in more detail)[28, 34, 35]. Continuing lack
of oxygenation can lead to the more dangerous metabolic acidosis associated
with long-term damage [27]. Metabolic acidosis is based on the production
of lactate and H+ ions via the anaerobic metabolism, which decreases the pH
and increases the lactate concentration [1]. A decrease in pH and elevated base
deﬁcit value is indicative of a metabolic acidosis as shown in Table 3.1 [28, 34].
Table 3.1: Threshold values of pH and base deﬁcit indicative of respiratory and
metabolic acidosis [14, 36].
pH Base Deﬁcit
Normal 7.36-7.44 -1.0-8.9
Respiratory Acidosis <7.36 -1.0-8.9
Metabolic Acidosis <7.36 >8.9
1The base deﬁcit represents the number of bases (chem.) that would neutralise the blood
to a pH of 7.2-7.4.
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An initial respiratory acidosis can lead to a metabolic acidosis if the normal
gas exchange cannot be established again. Since a lack of oxygen eventually
leads to cell death, a prolonged exposure to this situation can lead to postnatal
neurological complications. Hypoxic-ischemic encephalopathy can be a short-
term complication following intrapartum metabolic acidosis. The more severe
complication, cerebral palsy (2-3 per 1000 live births worldwide [37]) , leads to
long-term disabilities such as spastic quadriplegia [38]. Profound intrapartum
asphyxia can result in stillbirth (4.4 per 1000 in England and Wales in 2016
[39]) or neonatal death (1.9 per 1000 from 2001-2015 in England and Wales
[40])[35].
3.3 Past, Present and Future of
Foetal Monitoring
The ﬁrst report of using the foetal heart rate to screen for intrapartum foetal
wellbeing was in 1600s (Figure 3.2). Auscultation2 was initially undertaken
using stethoscopes (e.g. Pinnard) speciﬁcally designed for direct auditory aus-
cultation of the foetal heart rate through the maternal abdominal wall. Ultra-
sound is now used for external non-invasive assessment of foetal heart rate us-
ing devices such as hand-held sonic aids and cardiotocography (CTG). CTGs,
which measure both heart rate and uterine activity, can be used intermittently
or continuously [42, 43].
The latter technique was introduced because it was thought to provide a better
insight in foetal well-being (fewer Caesarean sections), which was found not
to be the case [44]. If it is not possible to auscultate the foetal heart rate
through the maternal abdominal wall, for example due to maternal adiposity
or foetal position, then a foetal scalp electrode (FSE) can be applied directly
2Auscultation: Listening to the sound oft he heart, lungs or a foetal heartbeat for the
purpose of a medical diagnosis or monitoring [41].
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Figure 3.2: History of the development of foetal monitoring. BGA= Blood Gas
Analyser [42].
to the foetal head to measure heart rate or foetal electrocardiogram (ECG).
The FSE, usually provides a more stable foetal heartrate signal, but there is a
higher risk of injury and infection [45] due to the device needing to puncture
the foetal scalp to obtain a signal. Foetal oxygenation has been proposed as
an alternative method of screening for intrapartum well-being. For the di-
rect measurement of foetal oxygenation, Kanayama et al. [46] developed an
oximeter with the sensor attached to the ﬁnger of the clinician. They were
able to measure foetal oxygenation in real time and intermittently. The group
of Nijland [47] developed a new transmission pulse oximetry device which is
embedded into the hook of a FSE. Although they have shown correlation be-
tween scalp oxygen and foetal oxygen concentration, modiﬁcations are required
to develop a more advanced version of an oximeter for future studies due to
remaining inaccuracies based on fabrication and calibration variations [47].
Although it was found by Nonnenmacher et al. [48] that foetal pulse oximetry
reduces the frequency of foetal scalp blood sampling (FSBS) when a non-
reassuring heart rate is observed, a systematic review conducted by East et al.
[49] recommended not to apply oximetry for intrapartum foetal monitoring.
In their study, the eﬃciency and safety of pulse oximetry for foetal monitoring
during labour was compared to CTG and ECG. They found that the comple-
menting CTG or ECG with oximetry does not reduce the rate of Caesarean
sections (CSs) [49].
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Finally, using the foetal ECG, ST-wave analysis (STAN) (where S and T are
segments in the ECG signal) was developed through an algorithm that anal-
yses the change in the ST-wave of the foetal ECG. Although initial studies,
conducted by Amer-Wahlin et al. [50], found that STAN correlated with foetal
hypoxia during labour [50], the additional use of STAN has shown to reduce
the need for FSBS and the number of CSs performed for foetal distress not
however, foetal outcome [50, 51, 52]. Although STAN provides additional
information, reduces the need for FSBS and commercial products based on
the technique are available, professionals still doubt if STAN can fully replace
foetal scalp blood sampling [53, 54].
3.4 Current Foetal Monitoring Process
Currently, during birth the maternal and foetal physiological parameters are
monitored by observing the foetal heart rate and the maternal contraction us-
ing cardiotocography (CTG). An example CTG signal is shown in Figure 3.4
(A)). As mentioned above, it can be troublesome to obtain a reliable signal
externally due to the position of the foetus, maternal obesity or in the case of
twin pregnancy.
Figure 3.3: Two foetal scalp electrodes. Attached with a screw and with a hook
[47, 55] (A)). Attachment of foetal scalp electrode [56](B)).
In these cases the application of a foetal scalp electrode can overcome these
problems and is attached to the foetal scalp by a small screw or a hook to
monitor the foetal heart rate [38, 55, 56]. However, monitoring the foetal
heart rate (using CTG or FSE) holds a high risk for unnecessary caesarean
sections and hypoxic babies due to a positive predictive value of 30% [44] and
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a negative predictive value to 86 % [57]. This means that although the heart
rate pattern presented is indicative of hypoxia and suggest intervention, the
foetus is well, which would lead to an unnecessary CS.
Figure 3.4: Process of foetal monitoring.
On the other hand, the heart rate pattern may not be indicative of any ab-
normalities or foetal compromise although the foetus might be suﬀering from
hypoxia. Therefore, FSBS is performed to obtain additional information about
the foetal well-being by measuring foetal blood pH and base deﬁcit, which helps
to distinguish between respiratory and metabolic acidosis. FSBS is repeated
up to three times. If the pH values are not within the thresholds, the foetus
is delivered through a caesarean section or an operational vaginal delivery. In
cases where the pH value is within the normal range the normal labour process
is continued. Foetal scalp blood sampling is recommended if the contraindica-
tions, listed in Table 3.2, can be excluded [2, 28, 58]:
Foetal scalp blood sampling is usually performed using a sampling kit, as
illustrated in Figure 3.5 [59]. For the procedure, the mother is in the lithotomy3
position to allow better access to the foetal scalp.
After preparing the sampling wand, by placing the capillary tube in its holder,
the amnioscope4 is inserted into the vagina. To prevent contamination from
the surrounding environment, the amnioscope is placed against the foetal scalp
3Lithotomy position: A supine position of the body with the legs separated, ﬂexed, and
supported in raised stirrups.
4Amnioscope: An endoscope that, is introduced into the cervical canal.
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Table 3.2: Contraindications for Foetal Scalp Blood Sampling [2].
Contraindications for foetal scalp blood sampling
Clinical picture demands early delivery
Cervix 3 cm dilated or thick meconium with scanty ﬂuid
Pathological heart rate prompts immediate delivery
Changes are due to oxytocic overstimulation
Clotting disorders in the foetus are suspected
Mother infected with blood-borne infection such as HIV, hepatitis B/C
If spontaneous vaginal delivery is imminent
Easy instrumental vaginal delivery is possible
During or soon after, prolonged bradycardia
Figure 3.5: Foetal Scalp Blood Sampling Kit [59]:1.Amnioscope+Obturator,2. Light
source, 3. Sampling wand, 4. Swabs, 5.Petrolium Jelly, 6. Sponge-holding forceps, 7
High heparine capillary tubes, 8 Tube holder, 9 Tube covers.
skin. To obtain a pure sample, the foetal skin is cleaned with cotton swabs,
which can also be used to move hair, if necessary. The scalp is numbed,
and perfusion is promoted by applying ethyle chloride and petroleum jelly
respectively [60].
The incision is made by a small scalpel, which is located at the distal end of the
sampling wand. After a suﬃcient blood drop has formed, it is collected with
the heparinised capillary tube mounted on the sampling wand. The sampling
system is retracted to retrieve the capillary tube, which is then closed with tube
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caps on both ends. Additionally, to prevent clotting and bubble formation, a
mixing wire can be added to the tube if a delayed insertion of the sample
into the blood gas analyser (BGA) is expected. The amnioscope is removed
from the vagina, whereby the blood sample is then inserted into the BGA for
analysis [60]. This procedure may vary depending on the kit used and the
guidelines in the respective hospital.
FBS is laborious, prone to errors (20% error rate [61]), invasive and it has also
been criticised for not having been proven to be beneﬁcial for foetal health
and the associated complexities [62, 63, 64]. Furthermore, it does not pro-
vide continuous and real-time information about the well-being of the foetus.
Therefore, alternative measurands representing foetal health status with the
ability to distinguish between respiratory and metabolic acidosis, are being
researched [6].
3.5 Diagnostic Parameters
The following measurands can be utilised in foetal blood sampled during FSBS,
with the results obtained being used to diagnose foetal acidosis and determine
clinical management. The advantages and disadvantages of each measurand,
and clinical implications of abnormal results are summarised below.
3.5.1 pH
By deﬁnition, the pH value is the negative logarithm to the base 10 of the
hydrogen ion (H+) concentration in a solution. The pH value (Equation (3.1))
is expressed in mol/L [31]. This measurand plays an important role ﬂuctuating
between 7.2 and 7.4 to maintain normal metabolic processes.
pH = − log10(H+) (3.1)
The lower the pH, the more acidic a solution is. When the hydrogen ion
concentration equals the hydroxyl ion (OH ) concentration, the pH is 7.4
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and represents a neutral solution like water. The pH value in the human
body is inﬂuenced by hydrogen ion concentration and the partial pressure
of carbon dioxide (pCO2) [34]. Therefore, the pH value in the body can be
regulated by the depth and frequency of breathing (which regulates pCO2)
and by the kidneys (which regulate H+). In the foetus, the pH value is mainly
regulated by gas exchange at the placenta, which makes it more susceptible to
any disturbance in foetal-maternal respiration [65]. The pH can be acquired
for foetal monitoring. When the oxygenation of the foetus is insuﬃcient, more
H+ ions are produced, which leads to a lower pH value as described above.
Currently the pH value is a common measurand for foetal monitoring using
the thresholds given in Table 3.3.
Table 3.3: pH thresholds for foetal monitoring [35].
Interpretation pH Clinical Decision
Normal ≥7.25 Repeated sampling within an hour if in-
dicated by CTG trace
Borderline 7.21-7.24 Repeated sampling within 30 minutes
is indicated by CTG trace
Abnormal ≤7.20 Delivery of baby
3.5.2 Base Deﬁcit
The base deﬁcit (BD) represents the number of bases (chem.) that would
neutralise the blood to a pH of 7.2 - 7.4. It is representative of the foetal
reserves and enables to diﬀerentiate between a respiratory and metabolic aci-
dosis, which is an important parameter in clinical decision making during birth
[66]. The carbonic acid (H2CO3)-bicarbonate (HCO3  ) buﬀer is represented
by the following equation (Equation (3.2))[67]:
H+ +HCO3
− ↔ H2CO3 ↔ CO2 +H2O (3.2)
The produced carbon dioxide (CO2) is eliminated through the gas exchange
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at the placenta [68]. The base deﬁcit is calculated from pCO2 and HCO3  by
using a derived algorithm (Equation (3.3)) of the Siggard-Andersen chart [27].
BD = −0.9149 · (0.12 · pCO2 · CO2 · 10pH−6.1 − 24 + 16.21 · [pH − 7.4]) (3.3)
The normal range for base deﬁcit is -1.0-8.9 mmol/L [28]. A value of 12
mmol/L is associated with severe newborn complications and is, therefore, the
threshold for foetal metabolic acidosis [69]. The base deﬁcit has the capability
to distinguish between respiratory and metabolic acidosis, and therefore it
has been used as an additional measurand for foetal well-being not only as
retrospective but also as an intrapartum monitoring analysis in addition to
pH analysis. However, the base deﬁcit is not a measured but an artiﬁcially
calculated parameter. Diﬀerent equations are used to calculate the base deﬁcit
and it has been found that diﬀerent blood gas analysers use diﬀerent algorithms
for the determination of the base deﬁcit [67]. A correlation between foetal
vitality and base deﬁcit has only been found in severely aﬀected new-borns.
Additionally, the base deﬁcit does not only represent a change in the acid-
bicarbonate system but is a measurand for all buﬀering systems in the body.
Therefore, the base deﬁcit is not suggested to be used as a parameter for the
determination of foetal well-being and lactate measurements should be used
instead [68].
3.5.3 Lactate
As explained in Section 3.2 lactate is the end product of anaerobic metabolism,
due to the lack of oxygen (O2). Whether the energy in the foetus is produced
under aerobic or anaerobic circumstances depends on the oxygen supplied by
the mother. During the second stage of birth, which is dominated by con-
tractions, the perfusion in the placenta can be restricted, leading to oxygen
deﬁciency [33]. For an easier comparison of the three diﬀerent parameters have
been summarised in Table 3.4 [35]. The lactate values have been added for
an approximate comparison. It has been shown that the thresholds for lactate
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values diﬀer depending on the device and need to be determined separately
[70].
Table 3.4: Respiratory and metabolic acidosis value of pH, base deﬁcit and lactate.
R.A = Respiratory Acidosis, M.A. = Metabolic Acidosis[28, 35, 69].
pH BD Lactate [mmol/L] Interpretation
Normal 7.36-7.44 -1.0-8.9 ≤ 4.1 Normal
R.A. <7.36 -1.0-8.9 4.2-4.8 Borderline
M.A. <7.36 >8.9 ≥ 4.9 Abnormal
Lactate is more speciﬁc and more sensitive to predict foetal outcome and is
therefore a potential alternative for pH [71, 72]. Hospitals in Sweden and
Australia are replacing pH measurement with lactate measurements for FSBS
[73, 74]. However, since pH has been used for clinical decision-making during
birth it has been found that clinicians ﬁnd it easier to base their decisions on
pH values rather than lactate values. Rørbye et al. [75] have found, that if
they based their decisions on lactate, it would have increased the operational
delivery rate by as much as 30% [75]. It has also been suggested to measure
lactate only during the ﬁrst stage of labour, due to the lactate values gener-
ally being higher during the second stage, which could lead to unnecessary
operational deliveries [45]. Therefore, the combined measurement of pH and
lactate was considered as an alternative to pH measurements only. However,
Wiberg-Itzel et al. [76] have found that when lactate and pH is used side by
side to determine foetal well-being, it may increase the operation delivery rate
without decreasing the rate of metabolic acidosis. On one hand, Liljeström
et al. [73] ﬁndings correlate with these results. They concluded that pH and
lactate diﬀer in 55% of the cases, but on the other hand they have also shown
that it reduces the number of operational deliveries from 95% to 66% compared
to measuring pH values only [72].
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3.6 Bioﬂuids
The complex circumstances during labour only allow access to either foetal
blood or interstitial ﬂuid. Blood has many diﬀerent functions in the human
body. One of the main functions is to transport O2 and nutrients to the organs
and tissues while collecting waste products and CO2 for disposal [77]. Regard-
ing lactate, blood is used as a transport system to distribute and eliminate
lactate. Interstitial ﬂuid (IF) is the ﬂuid that surrounds all cells in the human
body. It holds diﬀerent electrolytes and is a component of the extracellular
ﬂuid, which also includes blood plasma and lymph. The IF can be considered
as a transport system between the cells and the blood vessels and has a similar
composition to blood, with a lower concentration of proteins [78]. Currently
blood is sampled for foetal monitoring. Due to its less invasive access IF has
gained more attention in research for lactate detection. However, there is an
on-going discussion about whether blood or IF serves as a better sample for
lactate detection [79, 80, 81, 82]. There are only a few groups that have stud-
ied the correlation between lactate values in blood and interstitial ﬂuid. One
consistent conclusion is that there is a time delay between the lactate values
in blood compared to the lactate value in IF [79, 80, 81, 82]. In these studies
ranging from the year 1994 to 2012, lactate levels were either measured in
humans during exercise [79, 81], after overnight fasting [80] and in critically ill
patients [82]. Although diﬀerent bioﬂuids were used for lactate measurements,
they were all compared to blood lactate values. Most of the papers report
a delay of 6-10 minutes between blood lactate and IF lactate concentrations
[79, 80, 81]. However, if foetal lactate concentrations are observed continuously,
the trend of the concentration measured may provide enough information for
clinical decision-making. A study comparing blood and tissue lactate in criti-
cally ill patients utilising microdialysis, has found that the correlation between
blood and tissue lactate increases with time [82]. Another ﬁnding of this study
conducted by Kopterides et al. [82] was that blood lactate is generally lower
than tissue lactate, contrary to other ﬁndings in which the blood lactate is
always higher than the tissue lactate [81]. One explanation could be that,
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in this study by Kopterides et al. [82], the lactate was measured in patients
experiencing shock. They only found higher tissue lactate level (compared to
blood lactate levels) in patients with shock (compared to patients who were
not in shock). It has to be taken into consideration that those measurements
were not taken from foetuses but from adults whose physiology is diﬀerent.
In conclusion, it can be said that lactate concentration always rises ﬁrst in
blood and then in the tissue. Although professionals agree on the time delay
between the lactate concentrations in blood and in interstitial ﬂuid, there is
no agreement about the way those two concentrations correlate.
3.7 Conclusions
Although foetal monitoring has improved over the past two centuries, there
is a common agreement amongst professionals that foetal monitoring during
birth requires improvements with regard to its non-invasiveness, its sensitiv-
ity, speciﬁcity and reliability. Current methods are laborious, prone to errors
and invasive [62, 63, 64]. Lactate has been identiﬁed as potential alternative
measurand for intrapartum foetal monitoring, due to its ability to distinguish
between diﬀerent types of acidosis. Therefore, lactate has been chosen as a
measurand for the development of new monitoring device for foetuses during
birth. It is important to fully understand the foetal physiology and to take the
stages of labour into consideration, when using lactate as the key parameter
for clinical decision-making [6]. Once conﬁdence in the technique has been
gained, measurements of lactate concentration may be used in the future for
intrapartum foetal monitoring.
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4 Literature Review:
Technical Perspective
4.1 Introduction
In the previous chapter, the clinical need for an improvement of foetal moni-
toring during birth was pointed out and lactate was identiﬁed as a potential
alternative to the current pH detection based on foetal scalp blood sampling.
This chapter presents a coherent technical literature review on potential so-
lutions to achieve this. In order to measure lactate, a bioﬂuid needs to be
excessed ﬁrst for subsequent measurements. Potential sampling methods are
explored in that eﬀect. Secondly, the chapter explores the means of how lac-
tate is recognised in biosensing and how these recognition elements can be
attached to a biosensor surface. Subsequently, the key transduction methods
for lactate detection and materials for biosensors are introduced. The out-
come of a patent review regarding lactate sensing and foetal monitoring is also
provided to complete the overview about the technologies in the ﬁeld. Lastly,
the experimental way forward based on the literature review is outlined in the
conclusions section.
4.2 Sampling Bioﬂuids
In section Section 3.6 blood and interstitial ﬂuid have been introduced as
potential bioﬂuids to be sampled for foetal monitoring during birth. The fol-
lowing literature review on sampling bioﬂuids presents microdialysis and the
use of microneedles as the two potential sampling methods. The sections will
also include the description of their functionality and current advances.
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4.2.1 Microdialysis
Microdialysis follows the same mechanism as normal dialysis but on a smaller
scale. A microdialysis probe consists of an inside tube, the inlet, and a second
tube surrounding the ﬁrst one, the outlet as shown in Figure 4.1. The outer
surface area is made of a semipermeable membrane of a particular pore size
depending on the substance to be sampled [83]. After inserting the probe into
the tissue, a perfusate is pumped into the probe through the inlet ﬂowing back
through the outlet. The substance to be analysed (e.g. the lactate) experiences
a concentration gradient between the perfusate and the surrounding ﬂuid. As a
consequence, this substance diﬀuses down the concentration gradient into the
perfusate. The perfusate containing the sampled substance is called dialysate
[84]. The dialysate is then transported to the sensing element at the distal end
of the microdialysis catheter.
Figure 4.1: Sketch of microdialysis probe (left) in interaction with cells and blood
capillaries in the human body.
Microdialysis has been primarily used in research to sample analytes. It is
used in combination with electrochemical sensors for the measurement of the
concentration of lactate [79, 85], glucose [85, 86], potassium [87].
Using microdialysis for sampling in a sensing device improves the selectivity
due to the semi-permeable membrane only allowing substances of a certain tar-
get size to diﬀuse [85]. Furthermore, the membrane works as a physical barrier
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between the sensing element and the body ﬂuid, reducing bio-fouling and pro-
tecting the body from possible reactions towards materials and reagents used
for the sensing electrode. Microdialysis probes are as small as about 240-500
µm in diameter [88] and therefore it is a useful sampling method for point
of care applications. However, due to the time the analyte requires to diﬀuse
into the perfusate, this approach only provides a limited time resolution, which
makes it less attractive for the intended application. Time resolutions between
1-30 minutes for glucose and lactate have been reported for microdialysis sam-
pling [84, 85, 89, 90]. When using microdialysis there is also the risk of small
substances diﬀusing into the interstitial space (space between the cells and the
blood capillaries). The depletion of the analyte at the area surrounding the
probe, may lead to false results.
4.2.2 Microneedles
Microneedles are small needles(25 -2000 µm in height) [91] (usually arranged
in an array) used to either access blood or interstitial ﬂuid or to deliver a drug.
Depending on the application diﬀerent types of microneedles are used. They
are divided into hollow [92], solid [93] and biodegradable [94, 95] micronee-
dles (Figure 4.2). The delivery of drugs [93] and glucose monitoring [96, 97]
have played a major role in the development of microneedles. The fabrica-
tion methods for microneedles vary depending on the material and applica-
tion. The most common fabrication techniques are photolithography/photo-
etching, laser cutting, metal electroplating/electropolishing and micromould-
ing [17, 98, 99, 100, 101, 102, 103, 104, 105, 106].
Figure 4.2: Diﬀerent types of microneedles applied to the skin. Solid microneedles
(left), Dissolving microneedles (middle) and hollow microneedles (right) [96].
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Solid microneedles are fabricated from silicon [107], metal [108], and polymers
[109]. They are used for sensing and drug delivery. An electrochemical sensor
for lactate and glucose based on solid microneedles was developed by Vasylieva
et al. (Figure 4.3) [109]. The microneedles were fabricated from SU8 polymer
onto which three-electrode system was deposited. In vitro and in vivo tests
have been executed successfully. For delivering drugs with solid microneedles
they are coated with the speciﬁc drug. That layer will then dissolve upon
application into the skin. Gill et al. [93] have developed a controllable process
utilising micro-dipping to coat solid microneedles with enzymes amongst other
substances [93].
Figure 4.3: Silicon/SU8 microneedle multi-electrode sensor on a 3 mm microneedle
[109].
Hollow microneedles are made from silicon and polymers and are used for
biosensing and for the delivery of drugs. A hollow microneedle lactate biosen-
sor has been developed and investigated by Windmiller et al. [110]. An array
of pyramidical microneedles has been manufactured by a UV rapid prototyping
technology and ﬁlled with metallised carbon paste (Figure 4.4). A response
time of 15 seconds was achieved with a negligible rate of interference which is
indicative of a good selectivity shown by recording the current of lactate and
lactate with diﬀerent potential interfering substances (ascorbic acid, uric acid,
and acetaminophen). All solutions exhibited the same current values, which
can also be clearly distinguished from a the negative control [110].
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Figure 4.4: Microneedles ﬁlled with metallised carbon paste [110].
Biodegradable microneedles are made from biodegradable polymers and sugars
for the delivery of drugs, which dissolve after applied to the skin [111]. The
drug is encapsulated in the polymer/sugar during the fabrication process. The
common fabrication process is micromolding. Sullivan et al. have developed a
biodegradable microneedle patch (Figure 4.5) for inﬂuenza vaccination [112].
They have shown that the microneedles safely dissolve into pork skin within
minutes.
Figure 4.5: Example of biodegradable microneedles [112].
The dimensions and geometry of microneedles determine and inﬂuence their
mechanical strength and pain sensation. This has been tested computationally
and experimentally [113, 114, 115]. Microneedles have to be long enough (100
- 2000 µm) to reach interstitial ﬂuid or blood vessels and requires a thin sharp
tip to minimise potential nerve contact. The longer a needle is, the more likely
it is to reach the nerve endings in the dermis (approx. 200 - 2000 µm from the
skin surface) [116] (Figure 4.6), such as in the case of a hypodermic needle.
Davis et al. [115] have assessed diﬀerent microneedle geometries regarding
their insertion force and the maximum force before structural failure. The mi-
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croneedles were fabricated from polyethylene terephthalate (PET) coated with
a layer of titanium and copper. The insertion force has been found to be in
the range of 0.1 - 3 N, low enough for manual insertion. The force required to
break the needles was found to be around 3.8 N for most sizes and geometries,
which is beyond the manual insertion force [115].
Figure 4.6: Representation of the skin microanatomy [117].
More practical studies have looked at the pain sensation and the skin irritation
induced by the microneedles. It was proven that an increasing number of
microneedles in an array and the microneedle length both increase the pain
sensation [113]. The irritation of the skin after the application is dependant
on the shape and dimension of the microneedles. The degree of irritation is
compared to tape stripping [114], returning to a no-irritation state two hours
after the application. The skin irritation experienced from the application from
microneedles can, therefore, be classiﬁed as minimal [114]. This would be an
improvement to the current method of foetal scalp blood sampling using a
scalpel. A patent for a microneedle lactate sensing device has been registered
as Lactate measuring device and method for training adjustment in sports by
Jun-Tang Huang. The device describes a microneedle patch for the continuous
measurement of lactate during exercise. The microneedle size is 10 - 1,000 µm
in height and 150 - 450 µm base width [17, 98, 99, 100, 101, 102, 103, 104, 105,
106].
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Due to their size and shape, microneedles have several advantages compared
to normal hypodermic needle applications. Both the advantages and disad-
vantages are listed in Table 4.1 [111].
Table 4.1: Advantages and disadvantages of microneedles [111].
Advantages Disadvantages
Reduced pain and wounds Still invasive
Combinational possibilities Skin irritation
Minimally invasive Stability
Can sample interstitial ﬂuid and blood Diﬃcult application
Lowered risk of infection
Enables continuous sampling/monitoring
4.2.3 Conclusions
Microdialysis and microneedles have been found to be the current means of
sampling in research for biosensing and therefore also for lactate sensing. Al-
though microdialysis has several advantages over microneedles including its
higher selectivity due to the semi-permeable membrane, microdialysis requires
the addition of equipment and ﬂuids such as a pump and perfusate. Diﬀerent
microneedles have been developed successfully. Solid and hollow microneedles
can be used potentially for the application of foetal monitoring during birth.
The sizes and mechanical strength found in the literature are compatible with
the aim of this project. Based on these characteristics microdialysis is not
suitable for the aim of this project and microneedles will be explored further
for the purpose of developing a foetal monitoring device (Section 5.3).
4.3 Recognition
The recognition element for lactate detection is enzymes. There are two dif-
ferent enzymes that are used to recognise lactate. Lactate oxidase (Lox) [118]
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and lactate dehydrogenase (LDH) [119]. These enzymes will be described in
the following sub-sections.
4.3.1 Lactate oxidase
Lactate oxidase (Lox), also referred to as lactate mono-oxygenase, is a globular
ﬂavoprotein1 that promotes the oxidation of lactate to pyruvate in the pres-
ence of oxygen forming hydrogen peroxide (H2O2) [120]. H2O2 can then be
reduced or oxidised to determine the lactate concentration [121]. The reaction
(Equation (4.1a) and Equation (4.1b)) with lactate oxidase does not require a
co-factor [122, 123].
Lactate+O2
Lox−−→ Pyruvate+H2O2 (4.1a)
H2O2 → O2 + 2H+ + 2 e− (4.1b)
H2O2 requires a high potential to oxidise, which reduces the sensor speciﬁcity,
due to increases in interference from other substances, such as ascorbic acid,
uric acid, and acetaminophen, in the sample [123, 124, 125]. It has been shown
that interference can be eliminated or reduced by covering the sensing surface
with a Naﬁon2 [126] or electropolymerised thin ﬁlms [25], which improve
the selectivity of a sensor. From the chemical equations (Equations (4.1a)
and (4.1b), the reaction between lactate and lactate oxidase is dependent on
oxygen and thus susceptible to oxygen ﬂuctuations in the sample. This oxygen
dependency aﬀects the detection limit, manufacturing cost and miniaturisation
negatively [123]. However, as long as pO2 is not lower than 8 mmHg, the
chemical reaction is not aﬀected [127].
1A protein contains ﬂavin. It is involved in oxidation processes in cells.
2Naﬁonis a polymer, which is used as a membrane or coating
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The majority of the research being conducted on lactate sensors use Lox (Ta-
ble 4.2), of which most of these have the fastest response times (1-5 seconds).
An example of this research is given by Wei et al. [45], who have developed
a lactate sensor based on chitosan and have achieved a detection limit of 50
nM. The two lactate sensors with the fastest response also have the lowest
detection limits (3 pM and 50 nM) [128, 129], which is essential for a sensitive
biosensor.
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4.3.2 Lactate dehydrogenase
Lactate dehydrogenase (LDH) is a protein of great importance for the human
body. It is released to break down lactate in damaged tissue or muscles. LDH
also promotes the oxidation of lactate to pyruvate but instead of oxygen, it
requires the oxidised form of nicotinamide adenine dinucleotide (NAD+) for
the reaction to occur. NADH is the outcome of this reaction (Equation (4.2a)
and Equation (4.2b)) which can then be oxidised [123].
Lactate+NAD+ LDH−−→ Pyruvate+ NADH+H+ (4.2a)
NADH→ NAD+ +H+ + 2 e− (4.2b)
Lactate dehydrogenase (LDH) is more selective than lactate oxidase (Lox) due
to its oxygen independence [14, 119]. Furthermore, sensing with lactate de-
hydrogenase, qualiﬁes for optical sensing, due to the ﬂuorescent characteristic
of the co-factor NADH [133]. Besides these advantages, sensing with LDH
holds, however, a few disadvantages. LDH is an unstable protein and re-
quires high overpotential for the oxidation of NADH, which again is the cause
of interference from other substances, such as ascorbic acid, uric acid, and
acetaminophen, reducing the speciﬁcity of the sensor [119, 134, 135]. Further-
more, the substance produced during the chemical reaction can cause fouling
of the electrode thus impairing operational stability [134].
Less data on sensor characteristics, such as detection limit and response time,
is given in the publications of lactate sensors based on LDH (Table 4.3). Re-
searchers make use of the ﬂuorescent characteristic of NADH and have devel-
oped electrochemiluminescence (ECL) lactate sensors [136, 138]. To achieve
more sensitive lactate sensors based on LDH, additional reagents such as lumi-
nol are added [136]. However, luminol is not biocompatible because it causes
skin irritation and also has a negative impact on the digestive and the respira-
tory system and is therefore not suitable for in vivo applications [139]. Both
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advantages and disadvantages of lactate oxidase and lactate dehydrogenase are
summarised in Table 4.4.
Table 4.4: Summary of the advantages and disadvantages of lactate oxidase and
lactate dehydrogenase.
Enzyme Advantages Disadvantages
Lactate oxidase No co-factor required
Oxygen
dependency trace
Lactate dehydrogenase
Fluorescent
characteristic of the
cofactor NADH
Electro fouling is
more likely
Independent of oxygen
Despite being a disadvantage for LDH, there is a wide range of overpotentials
used for both enzymes. For both enzymes, high and low overpotentials have
been identiﬁed and are summarised in Table 4.5.
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Table 4.5: Overpotentials of lactate sensors based on Lox and LDH. GC=Glassy
carbon Pt=Platinum, AlGaAs=Aluminium gallium arsenide, LDH=Lactate dehydro-
genase, Lox=Lactate oxidase, AM=Amperometric.
Substrate Enzyme Transduction Working Potential [V] Ref.
Graphene LDH AM 0.48 [119]
GC LDH AM 0 [15]
Graphite LDH AM 0.35 [140]
Pt LOx AM 0.4 [128]
Carbon LOx AM -0.1 [141]
Pt LOx AM 0.65 [142]
Pt LOx AM 0.65 [143]
Glass LOx AM -0.05 [144]
GC LOx AM 0.5 [132]
AlGaAs LOx AM 0.5 [129]
Carbon LOx AM 0.3 [145]
GC LOx AM 0.1 [146]
Pt LOx AM 0.7 [127]
Pt Lox AM 0.7 [25]
Pt LOx AM 0 [147]
Pt LOx AM 0.65 [148]
4.4 Immobilisation
Immobilisation is the attachment of recognition elements (e.g. enzymes) to a
substrate or within a support material [7]. There are diﬀerent ways of immo-
bilising enzymes, which are shown in Table 4.6.
4.4.1 Adsorption
Physical adsorption is the attachment of enzymes through forces such as Van
der Waal forces, hydrogen bonding and hydrophobic interactions [150]. This
way of immobilisation is simple because neither enzymes nor the support need
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Table 4.6: Immobilisation methods [7, 149].
Support based Not support-based
Adsorption Cross-linking
- Physical
- Ionic
- Covalent
Entrapment/Encapsulation
to be charged. Another advantage of using physical adsorption is that the
support does not require much preparation. Activity is also maintained due
to the little deformation applied to the enzyme [150].
Ionic adsorption makes use of the electrostatic interaction between ions. The
connection between negatively and positively charged ions is dependent on the
surrounding pH, temperature, and ionic strength and forms the foundation for
the ion bonding. As it is a weak bonding, the enzymes do not experience much
deformation and the immobilisation is easily reversed. However, this can also
cause leaching making the sensor less eﬀective and stable [151].
Covalent adsorption is based on covalent bonding, in which two atoms share
electrons. Although this immobilisation method is a time-consuming process,
this attachment method forms a strong connection between the enzyme and
the support material, which makes it more stable and less prone to leaching.
However, this immobilisation method can lead to reduced enzyme activity due
to enzyme deformation, restricted enzyme movement, and blocking of active
sites [7, 149].
Table 4.7 summarises the list of lactate sensors using adsorption as the im-
mobilisation method. More than half of the listed lactate sensors meet the
required detection limit of 0.001 mM [15, 24, 124, 129, 137]. Most of those em-
ploy amperometry in combination with Lox [124, 132]. The sensors with the
lowest detection limit share the property that they both apply nanoparticles
to their substrate for the enhancement of the surface area [15, 129]. From this
table, the optical-electro-chemiluminescence (ECL) sensor achieved the lowest
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detection limit [15]. Immobilisation through adsorption seems to work well
with LDH as good detection limits and response times were obtained, achiev-
ing the fastest response times (of 1 second) in combination with optical ECL
sensors [138].
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4.4.2 Entrapment/Encapsulation
Immobilisation of enzymes by entrapment or encapsulation consists in the for-
mation of a lattice or matrix around the enzymes without forming a connection.
Due to the minimal modiﬁcation of the enzyme, activity is maintained and the
stability is increased. Furthermore, since there is no connection between the
enzyme and the support, the active sites do not get blocked [158]. However,
mass transfer can be impaired due to the dependency on the porous network
surrounding the enzymes. Common materials used for entrapment and encap-
sulation are sol-gel and hydrogel [159]. Sol-gel requires a non-biocompatible
precursor and forms alcohol-causing gel-shrinkage during the manufacturing
process [7, 149].
Table 4.8 provides a list of the sensors using entrapment/encapsulation to
immobilise the lactate sensing enzymes onto the substrate. Both sol-gel and
hydrogel seem to have the potential to detect lactate concentration as low
as 130 nM [41] and 6.4 nM [157], respectively. Immobilisation through en-
trapment/encapsulation is mostly used in combination with amperometric
transduction. Although good response times (2-7 seconds) have been achieved
[125, 132, 160], such sensors tend to have a slower response time such as 2:24
minutes and 15:12 minutes [85, 118]. This slow response may be due to the
diﬀusion barrier created through the gel around the enzyme, which is also a
protective barrier against the surrounding environment.
4.4.3 Cross-linking
Cross-linking uses a two-step process, which adds diﬀerent reagents to provide
suﬃcient immobilisation. Although this method forms a stable immobilisa-
tion of the enzyme and does not require additional support such as gels or
membranes, it may cause a conformational change, which reduces enzyme per-
formance. This method can be improved by using a support material such as
chitosan [7, 149].
Table 4.9 summarises the list of lactate sensors with cross-linked enzymes on
46
the substrate. More than half of the listed sensors utilising cross-linking oﬀer
a suﬃcient detection limit needed for foetal monitoring [24, 25, 110, 122, 140,
147, 153, 154, 155, 156, 157, 161]. The response time ranging from 5 s to 180 s
for the electrochemical sensors may not be entirely due to the immobilisation
method but be the result of diﬀerent protective layers employed, not allowing
fast diﬀusion. However, cross-linking is a common method for immobilising
enzymes and protocols are readily available [124, 142, 145, 162, 163].
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4.4.4 Conclusion
As the sensor will be in direct contact with human tissue, an immobilisation
method is required, which provides a strong bond between the enzyme and the
electrode surface, and prevents leaching. Covalent bonding and cross-linking
are most likely to provide a strong immobilisation of the enzyme. Therefore
these methods will be explored further for the development of the lactate sensor
for foetal monitoring during birth (Chapter 6).
4.5 Transduction
Transduction is deﬁned as the translation of the signal generated by the recog-
nition element into a measurable signal. This can be achieved by multiple
means such as electrochemical, optical and thermometric transduction. The
transduction method is dependent on the measurand, the signal obtained from
the recognition element and the output signal required [7]. The main transduc-
tion methods used for lactate detection are optical [118, 136] and electrochemi-
cal [122, 132] transduction . The basic underlying principle of these techniques
is explained in the following paragraphs.
4.5.1 Optical sensors
Optical sensors transform an optical signal, obtained at the recognition site,
into an electrical signal. In optical sensing, the system consists of the light
source and the light detector with the light source being an external light
source or light emitted by the analyte. The transmitted light is then received
by the light detector. There are diﬀerent types of optical detectors (Table 4.12),
which provide diﬀerent output signals.
Electro-chemiluminescence (ECL) and colorimetry have been utilised for lac-
tate sensing [133, 138, 172]. ECL is based on a (bio-) electrochemical reaction
resulting in a luminescence compound [7]. Colorimetry is used in combination
50
Table 4.10: Types of optical detectors [171].
Type Function
Photoresistor When light is applied to a photoresistor, its re-
sistance changes.
Photodiodes Change in electric current upon light applica-
tion.
Phototransistors A phototransistor is a combination of a photo-
diode and a transistor. The light intensity reg-
ulates the current ﬂow through the transistor
[87].
with a dye that changes colour in relation to the lactate concentration [172].
In lactate sensing, co-enzyme-based optical transduction plays an important
role. NAD+ is a co-enzyme for lactate dehydrogenase and display exhibits
characteristic absorption (350 nm) and ﬂuorescence (450 nm), enabling optical
detection[7].
Although optical sensing holds several advantages over electrochemical sensing
as deﬁned in Table 4.11, comparatively few researchers have explored optical
detection (Table 4.12) as an alternative method for the determination of lactate
concentration.
Table 4.11: Advantages of optical sensing [173].
Easy to miniaturise
Selectivity
Inexpensive
No reference signal required
Self-contained
Immunity to electro-magnetic interference
No electrical risk for patient
Li et al. [133] have encapsulated lactate dehydrogenase and NAD+ in silica
powder and ﬁlms. Due to the mild manufacturing method, suﬃcient enzyme
51
activity has been obtained for further development of a lactate sensor. How-
ever, their experimental design experienced enzyme leaching problems from
the sol-gel employed [133]. A more successful approach was achieved by Cai
et al. [136], who developed an optical biosensor for the detection of lactate in
sweat. Lactate oxidase was used for optical detection in combination with the
luminescent material, luminol, which provided a lactate sensor with a detection
limit of 8.9·10−10 mol/L [136]. Luminol is a luminophore with a signal inten-
sity enhanced by the by-product of the reaction between lactate oxidase and
lactate H2O2 [166, 167]. However, due to associated toxicity, luminol cannot
be used in vivo [139].
To develop a lactate sensor for cancer research, Zheng et al. [138] have studied
an optical sensor based on lactate dehydrogenase immobilised on the tip of a
nanoprobe, achieving a response time of 1 second. However, only concentra-
tions as low as 0.02 mM have been reported [138]. A few sensors based on
colour change related to the concentration of lactate have been studied, which
however require a microﬂuidic chip, adding to the complexity of the sensor
[168].
Although optical detection has a great potential for lactate sensing for intra-
partum foetal monitoring, due to the advantages stated in Table 4.11, little
proof has been identiﬁed for the suitability of this method for the intended
purpose.
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4.5.2 Amperometric sensors
An amperometric sensor measures the resulting current upon an applied poten-
tial. This current is equivalent to the measurand concentration. The physical
principle is outlined in in more detail in Section 6.3.2. Through an extensive
review of lactate sensors, it has become evident that the majority of the lactate
sensors utilise amperometry. These sensors are summarised in Table 4.13. All
the sensors listed achieve a detection limit of 0.003 nM - 600 nM [129, 161].
However, only two of those react within 1-6 seconds [129, 155]. The working
electrodes have been modiﬁed by diﬀerent means such as multiwalled carbon
nanotube (MWCNT) [15, 131, 132, 174], chitosan [128], nanowires [129] and
nanoparticles [119, 124]. Therefore, the functionalisation before the enzyme
immobilisation seems to be one of the important fabrication steps of a lactate
sensor. The sensors with a prompt reaction deploy a form of nanomaterial, gen-
erating a large electrochemical surface area for the attachment of the enzyme
and ultimately for the recognition of lactate. Wei et al. [128] have developed
an amperometric lactate sensor based on a platinum-chitosan electrode func-
tionalised with lactate oxidase achieving a detection limit of 50 nM within 1
second over a period of 24 hours. Chitosan is made from the chitin shell of
shrimps and is biocompatible and non-toxic. Windmiller et al. [110] have used
carbon paste in microneedles in combination with amperometric transduction.
Their research found negligible interference of other substances, however, their
operational stability was only tested for two hours. As an operational stability
of up to 24 hours is required for the foetal monitoring device, this is an impor-
tant parameter. Ma et al. [129] have developed a lactate sensor using a high
electron mobility transistor (HEMT) and zinc oxide (ZnO) nanowires. In this
HEMT based sensor, the drain current represents the lactate concentration in
the sample. Furthermore, the presented sensor does not require a reference
electrode, making it possible to minimise the required size of the gate. The
gate is made from aluminum gallium arsenide (AlGaAs), due to its high chem-
ical stability and good electron transport properties. However, toxic eﬀects
have been reported for AlGaAs, making it unsuitable for medical application
54
with potential direct contact with the patient [157].
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4.6 Materials
Two categories of materials are of main interest for biosensors, namely sub-
strate and surface-enhancing materials such as nanoparticles.
Depending on the transduction method, diﬀerent materials are used. For op-
tical detection, glass and optical ﬁbres are the preferred materials, enabling
the transportation of the light towards the light detector [133, 138]. For the
enhancement of the surface, materials such as carbon nanotubes, hydrogel,
and sol-gel have been applied [118, 133, 136].
For electrochemical lactate sensing the substrate is preferably fabricated from
gold [134], carbon [130], platinum [155] or glass [165]. The material is required
to be biocompatible , corrosion resistant and conductive to serve as a working
electrode for electrochemical sensing for medical applications.
4.6.1 Gold
Table 4.14 summarises lactate sensor based on gold electrodes. Lactate sensors
based on gold substrate react to lactate in a solution within 10 - 70 seconds.
The detection limits achieved based on gold electrodes was found to be between
1-15 µM [134, 170]. Lower detection limits have been found in lactate sensors
using platinum and carbon electrodes (0.1 nM and 0.5 nM) as presented in
Table 4.14. Although gold is a popular material for electronic fabrication and
is biocompatible, it is an expensive raw material. However, screen-printed gold
electrodes are commercially available [176] and gold is furthermore compatible
with the fabrication techniques available to this project.
4.6.2 Platinum
Table 4.15 lactate sensors using platinum as a substrate are listed. Platinum
has been used for electrochemical sensing because of its high electrocatalytic
activity [145], providing a good basis for immobilisation. Platinum is con-
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ductive, corrosion resistant and biocompatible. Platinum has been used more
frequently for lactate biosensors. Sardesai et al. [155] have tested a platinum-
based lactate sensor in rat tissue and obtained results within 6 seconds and
have detected lactate concentrations as low as 0.1 nM. The remaining Pt-based
lactate sensors listed in Table 4.15 require more time (50 - 180 seconds) and
cannot detect lactate concentrations as low as the sensor presented by Sardesai
et al. [155]. Additionally, screen-printed platinum electrodes are available to
purchase for research purposes [177]. Furthermore, platinum is also an eligible
material for the micro-fabrication processes.
4.6.3 Carbon
Lactate sensors based on carbon are provided in Table 4.16, showing both low
detection limits and fast response times. Carbon is another popular material
used as electrode material. It is very versatile and is used in diﬀerent forma-
tions. It is used as glassy carbon, which is corrosion resistant, conductive and
chemically inert. Carbon is also used in the form of graphene; a one-atom-thick
layer of carbon, which is very strong, conductive and provides a large surface
area ideal for surface functionalisation. Graphite sheets are ﬂexible, enabling
ﬂexible sensors for direct application onto skin. Perez and Fabregas [141] have
developed an amperometric lactate sensor based on carbon detecting lactate
concentration as low as 0.56 nM within 20 seconds. A faster response time of
2 seconds was achieved by Goran et al. [130] with carbon-based lactate sen-
sor. The detection limit, however, was signiﬁcantly higher (4.1 µM) than the
previously described carbon lactate sensor [141]. Carbon shows good potential
to serve as a substrate for lactate sensors. Despite the advantage of the use
of carbon for electrochemical sensor and their commercial availability [178],
carbon is not compatible with the fabrication process available to this project.
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4.6.4 Glass
Lactate sensor, based on glass substrates, are frequently used and are listed
in Table 4.16. However, because a conductive surface is required for electro-
chemical sensors, the glass substrate has been modiﬁed with layers of metal
or carbon such as ZnO [165] and nitrogen-doped carbon [130]. Ibupoto et al.
[165] have developed a lactate sensor using glass and ZnO nanorods achieving
a detection limit of 0.1 µM to be detected within 10 seconds. Faster lactate
sensors, which react within 2 seconds to a change of lactate concentration,
have been developed creating a substrate from glassy carbon in combination
with nitrogen-doped carbon nanotubes [130]. As microneedles are proposed
as the basis for the development of the lactate sensor, glass is not the ideal
choice as a substrate for the sensor because microneedles are mainly fabricated
primarily from polymers [179] or metal [172].
4.6.5 Nanomaterials
Nanoparticles are frequently incorporated in lactate sensors to enlarge the
surface area, providing possibilities for the enzymes to attach. Nanoparticles,
such as multi-walled carbon nanotubes (single or multi-walled carbon nan-
otubes [15, 141]) and carbon nanocubes serve as a bridge between the working
electrode and the site of the chemical reaction. They have advantageous char-
acteristics for biosensor applications because they create a large surface area,
have a high surface reaction energy, high sensitivity, and high catalytic eﬃ-
ciency. They also improve the response time and the ability to adsorb the
enzyme [123]. Nanoparticles can be applied to various materials such as gold,
glass, carbon and glassy carbon [15, 134, 141, 165]. However, nanomaterials
are potentially toxic [180] and as the sensor will be in direct contact with hu-
man tissue, they are not compatible with the development of the proposed
sensor.
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4.6.6 Conclusions
For the development of an electrochemical lactate sensor, the electrode needs
to be biocompatible, corrosion resistant and conductive. Furthermore, for the
initial development phase and for the second stage, involving the fabrication of
a sensor, it is necessary that the material can be processed using the electron
beam evaporator. For the above reasons, gold and platinum are the most
suitable for the sensor for foetal monitoring during birth.
4.7 Patent Review
In addition to the literature review, an extensive patent review has been con-
ducted regarding lactate sensing and foetal monitoring, utilising the database
Espacenet [185]. The patents have been categorised according to their detec-
tion method, namely, electrochemical, optical, electrical and other. In total
60 patent were reviewed. The reviewed patents were analysed and ﬁltered
according to the chart presented in Figure 4.7. Not relevant patents, such as
patents that do not cover pH, lactate and foetal monitoring and patents that
are not available in the English language, have been excluded. The patents
have then been further ranked regarding the key measurand (lactate, pH and
other). Following that, the ﬁve most relevant patents to foetal monitoring have
been identiﬁed [186, 187, 188, 189, 190] (Table 4.17).
Through the patent review, it has become evident that several approaches have
been made to simplify the process of FSBS by automating steps and devel-
oping a more contained device. However, most devices still have an invasive
approach and do not provide continuous real-time results. However, illustrated
in Table 4.17, there is a distinct tendency towards less invasive sampling for
lactate sensing, either through the application of microdialysis or micronee-
dles [188, 189, 190]. Although there are several advances within the ﬁeld of
lactate sensing and foetal monitoring, no patent has been found, fulﬁlling the
requirements laid out for foetal monitoring in Chapter 1
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Table 4.17: Results from patent review: Most relevant patents according to
the ﬁlters applied which are represented. MD=Microdialysis, MN=Microneedles,
EC=Electrochemical, NA=Not available.
No. Title Sampling Detection Ref.
1.
Device for determining foetal
reserves during childbirth
(2002)
Blood, IF EC [186]
2.
Implantable multi-parameter
sensing system and method
(2005)
Implanted EC/optical [187]
3.
Device for detecting oxygen
depletion in foetuses during
childbirth (2009)
MD. NA [188]
4.
Integrated electrode for
sampling of lactate and other
analytes (2015)
MD Enzymatic [189]
5.
Lactate measuring device and
method for training
adjustment in sports (2015)
MN. EC [190]
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Figure 4.7: Chart representing the ﬁlters applied for the patent analysis chart.
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4.8 Conclusion
Following a literature and patent review, a clear direction for the development
of a lactate sensor for foetal monitoring has been identiﬁed. For accessing either
interstitial ﬂuid or blood, microdialysis and microneedles are the options for
means of sampling. However, microdialysis is a complex process and therefore
less suitable for the application of intrapartum foetal monitoring. For this
reason, microneedles can be considered a more appropriate sampling method
due to reduced complexity than the microdialysis method, providing access to
the bioﬂuid and with the advantage of being minimally invasive.
For a greater speciﬁcity of lactate sensors, either lactate oxidase or lactate de-
hydrogenase are immobilised onto the working electrode. Both enzymes have
been shown to successfully provide a basis for lactate sensing, although, a sig-
niﬁcant proportion of published research focuses on the use of lactate oxidase.
As lactate dehydrogenase is a less stable protein and requires a larger over-
potential, lactate oxidase will be used for the development of the intrapartum
foetal monitoring in this work. Covalent bonding and cross-linking have been
identiﬁed as the most suitable means of immobilising the enzymes to the elec-
trode surface. This is due to the observed tendency to prevent leaching of the
enzyme, which is important when in contact with human tissue. Encapsulation
requires an additional gel that is not compatible with the use of microneedles
and, consequently, covalent binding and crosslinking are investigated for ap-
plication in this research.
Study of the available literature has shown that amperometry is the most
common transduction method for lactate methods, only requiring a potentio-
stat. The measured current is proportional to the lactate concentration in the
sample. Other means of transduction have been researched, but are not as ad-
vanced in their development. Thus, amperometric transduction will be utilised
for the development of the lactate sensor. The materials used for the working
electrode of lactate sensors include gold, platinum, carbon, and glass, which
can be further modiﬁed with nanomaterials. However, as nanomaterials can
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potentially leach and are toxic, they cannot be utilised for the development of
a foetal sensor. As gold and platinum electrodes are commercially available,
and both raw materials are compatible with the electron beam evaporator for
the fabrication of the sensor, gold and platinum will be explored experimen-
tally. This will provide further insight about the suitability for lactate sensing
for foetal monitoring.
The patent review conducted underlines the proposed direction for the devel-
opment of an intrapartum foetal monitoring sensor. There is a clear trend of
less invasive application to monitor babies during birth, for which microneedles
and microdialysis have been utilised.
In conclusion, the work in this thesis will be focused towards the development
of a prototype sensor in which lactate oxidase is employed as a recognition
element, which is immobilised onto microneedles using covalent binding and
crosslinking and the resulting signal is transduced through amperometry. Gold
and platinum are to be investigated as materials for the working electrode.
67
5 Methods and Results:
Sensor Fabrication
This chapter provides information about the materials and methods used for
the fabrication of the sensor prototype. Firstly, commercial electrodes are
introduced from which the sensor design will be adapted for the developmental
phase. This design is presented and explained in Section 5.2 after which the
fabrication process and characterisation methods are introduced. Lastly, the
results of the characterisation of the commercial electrodes and the prototype
are presented.
5.1 DropSens Electrodes
For the development of the lactate sensor, commercial screen-printed electrodes
were purchased from DropSens. These electrodes are intended for single use
measurements and can be modiﬁed with regard to the immobilisation of en-
zymes for example. For the purpose of this project, gold [176] and platinum
[177] electrodes were acquired, a specimen of which is are represented in Fig-
ure 5.1. These electrodes are based on a ceramic substrate with a length of 33
mm, a width of 10 mm and height of 1 mm. Both electrodes have 4 mm di-
ameter working electrode and a silver reference electrode. All electrochemical
measurements were performed on these DropSens electrodes.
Figure 5.1: Example of DropSens unmodiﬁed screen-printed electrodes. WE =
Working Electrode, CE = Counter Electrode, RE = Reference Electrode.
A connector, provided by DropSens, was purchased in order to connect the
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electrodes to a potentiostat. The electrode is plugged into the slot as indicated
in Figure 5.2(B).
Figure 5.2: DropSens connector. A) Side view. B) Front view: Slot for electrode.
C) Back view: Connection for potentiostat.
5.2 Aim
The aim of this chapter is the development and the fabrication of a prototype
electrochemical sensor. The electrode will be based on a three-electrode system
as described in Section 2.1. The pattern for this three-electrode system will be
adapted from the DropSens electrodes introduced in Section 5.1. As the aim is
to apply the sensor to the foetal scalp during birth, the three-electrode system
will be applied to a microneedle array for access to the bioﬂuid and electro-
chemical measurement. This is done to improve the laborious and erroneous
method currently applied (Section 3.4) in size, duration and invasiveness. A
schematic drawing of the sensor prototype is given in Figure 5.3. The sen-
sor prototype will consist of two parts. Firstly, the microneedle array with the
electrode pattern. Secondly, a printed circuit board to connect the microneedle
array with the potentiostat.
Figure 5.3: Schematic drawing of the composition of the electrochemical sensor for
the development phase.
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Figure 5.4 shows how the sensor is connected to the potentiostat using the
DropSens connector for measurements. The sensor in Figure 5.4 is represented
by the blue chip above the DropSens connector in the right-hand box. In order
for the fabricated microneedle sensor to ﬁt into the connector, an adapter,
which is labeled Copper PCB in Figure 5.3, is required.
Figure 5.4: Connection between the sensor and the potentiostat using the DropSens
connector.
5.3 Microneedles
For the development of the electrochemical lactate sensor for foetal monitor-
ing during birth, the microneedle array must not be larger than 1x1 cm to
provide monitoring from an early stage of labour. Furthermore, the micronee-
dles must be made from a non-conductive material to create a three-electrode
system from deposited metal on top of the microneedle arrays. For the ﬁnal
device, the microneedle arrays need to be biocompatible as it will be in direct
contact with human tissue. A search for commercially available microneedles
was undertaken. Two companies, namely MicroPoint [191] and Innoture [192],
were identiﬁed to fulﬁll the criteria outlined above. Samples from both com-
panies were acquired for inspection with regard to the following fabrication
processes. Firstly, the microneedles by MicroPoint are introduced. Secondly,
the microneedles samples supplied by Innoture are presented in this section.
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5.3.1 MicroPoint Microneedles
A sample of the microneedle arrays purchased from MicroPoint is shown in
Figure 5.5. The image was acquired using a Dino-Lite camera. The micronee-
dle arrays are made from Poly(methyl methacrylate) (PMMA) and each has
15x15 microneedles on a square of the size of approximately 8x8 mm. Each
microneedle is 500 µm in height and a base thickness of 200 µm. The distance
between each microneedle (pitch) measured from centre to centre, is 500 µm.
These characteristics are summarised in Table 5.1.
Figure 5.5: PMMA Microneedle Array with 15x15 microneedles.
Table 5.1: Characteristics of MicroPoint microneedle array.
Property Value
Material Poly(methyl methacrylate) (PMMA)
Height 500 µm
Base width 200 µm
Pitch 500 µm
Size 15x15 microneedles
Dimensions ≈ 8x8 mm
5.3.2 Innoture Microneedles
In addition to the microneedles, sourced via MicroPoint, Innoture provided mi-
croneedle array samples (Figure 5.6). The sample sheet contained microneedle
arrays of diﬀerent pitches; 600µm, 800µm and 1000µm. All parameters are
summarised in Table 5.2. Figure 5.6 shows the three diﬀerent arrays with
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a magniﬁed image of the needles below, which were taken using a Dino-Lite
camera.
Figure 5.6: Innoture microneedle arrays and respective close-up images using the
Dino-Lite camera.
The microneedles are constructed from a thin ﬂexible laminate and are there-
fore not suitable for the fabrication process, due to heat development .
Table 5.2: Characteristics of Innoture microneedle array.
Property Value
Material Laminate (ﬂexible)
Height 600 µm
Base width 200 µm
Pitch Variable (600, 800, 1000 µm)
Diameter of array approx. 1.5 cm
The initial inspection of the microneedle samples provides by MicroPoint and
Innoture, concluded that the microneedle arrays supplied by MicroPoint, ﬁt
the requirements for the microneedle sensor prototype. Therefore, the fabri-
cation process was tested with the MicroPoint microneedle arrays. However, a
conﬁdentiality agreement between Heriot-Watt and Innoture has been estab-
lished for future collaboration.
72
5.4 Fabrication
5.4.1 Patterning using Tape
In this section, the development of the fabrication process is presented. Dif-
ferent options for the deposition of the metal three-electrode system were con-
sidered including electroplating which was rejected since it requires two con-
ducting electrodes (one of which would be the microneedle array), which the
PMMA microneedle arrays is not. In addition to that, sputtering was consid-
ered but was also rejected as it is more likely to damage to surface from im-
pacting atoms. Electron beam evaporation was chosen as the means to deposit
metal onto the microneedle arrays because it provides a conformal deposition
of the metal due to its higher vacuum. The compatibility of the electron beam
evaporation with the microneedle arrays was investigated. The microneedle
arrays were exposed to the deposition process and the result was examined for
damage on the microneedles. For the initial test, the microneedle array was
masked, using an adhesive-free tape (Polytetraﬂuoroethylene (PTFE) tape) to
avoid microneedle contamination. The PTFE tape was purchased from Sigma-
Aldrich. The microneedle array was masked manually using the PTFE tape
by carefully wrapping it around the rows of the microneedle array that will not
be exposed to the deposition. An example of the masked microneedle array is
shown in Figure 5.7(left).
Figure 5.7: Microneedle array masked with PTFE tape (left). Schematic drawing
of were metal will be deposited. The blue areas will be deposited with silver (right).
In that way, the pattern shown schematically in Figure 5.7 (right) was de-
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posited onto microneedle array (blue= metal deposition) by following the three
masking steps presented in Figure 5.8 in which the grey areas represent the
PTFE tape and the visible microneedles were exposed to the metal deposition.
The metal deposition was carried out by the student using a electronn/beam
evaporator, after appropriate training.
Figure 5.8: Schematic drawing of the three diﬀerent masking steps in order to
achieve three stripes of silver deposition as presented in Figure 5.7 (right). The grey
areas represent the masked microneedle rows.
The appropriately masked microneedle array (placed on a silicon wafer) and
the crucible containing the metal was placed into the electron beam evaporator.
The metal used at this stage was silver because it is more economical for a test
run than gold or platinum. After the chamber was evacuated to a high vacuum
of 2 · 10−5 mbar, silver was deposited by heating the silver in the crucible
by an electron beam created by a high current passing through a tungsten
ﬁlament. This causes the metal to melt and due to the vacuum, the metal
vapour evaporated onto all the exposed surfaces in the chamber, depositing
a uniform and measurable layer of atomic thickness of 300 nm. This was
controlled by a crystal piezo sensor inside the chamber. Silver was deposited
in three steps indicated in Figure 5.8. These were conducted three times to
achieve the pattern introduced in Figure 5.7 (right). The time required for
one cycle of deposition is listed in Table 5.3. The durations listed cannot be
improved using this device. However, the number of arrays added into one
deposition step can be increased to make this process more eﬃcient.
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Table 5.3: Electron-beam evaporation steps and durations.
Step Duration
Warming up pumps 30 minutes
Roughing (atmospheric pressure to 1 · 10−1 mbar) 30 minutes
Backing (1 · 10−1 − 2 · 10−5 mbar) 1.5-2 hours
Evaporation 5 minutes
Cooling down 30-60 minutes
Shutting down system 20 minutes
Total ≈4.5 hours
5.4.2 Patterning using PMMA Mask
As the masking method applied in the testing deposition is time-consuming,
not repeatable and is challenging to form complex geometries, a new mask-
ing method was developed. A masking jig, as shown in Figure 5.9, was de-
signed using AutoCAD (Autodesk) based on the electrode pattern used on the
DropSens electrodes. The middle cut-out will create the working electrode, the
left cut-out will create the counter electrode and the right cut-out will create
the reference electrode (Figure 5.9 B). The masking jig consists of a bottom
patterned substrate (Figure 5.9A) and a top mask (Figure 5.9B) which were
both fabricated from PMMA sheet utilising an Epilog laser cutter. The bot-
tom jig was fabricated from 2 mm thick PMMA and the mask from 0.5 mm
thick PMMA.
Figure 5.9: Improved masking jig (A) and mask (B) made from PMMA using a
laser cutter. Image (C) shows how the mask is placed on the jig.
The settings used for the laser cutter are listed in Table 5.4. To test the func-
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tionality of the new mask, a plain 1 mm thick PMMA sheet was used instead
of the microneedle array to ensure an optimal fabrication process before apply-
ing to the microneedle arrays. The PMMA sheet representing the microneedle
array was also cut using the Epilog laser cutter. The settings are also listed in
Table 5.4. Using this masking method reduces the deposition time by 30% as
only two deposition cycles are required.
Table 5.4: Epilog laser cutter setting to cut diﬀerent thicknesses of PMMA.
Thickness Speed Power
0.5 mm 30% 20%
1.0 mm 30% 80%
2.0 mm 25% 90%
The bottom jig was placed onto a silicon wafer to ﬁt into the holder in the
electron beam evaporator and ﬁxated with double-sided tape. The dummy
substrate was placed into the bottom jig (Figure 5.9 A). The mask is securely
placed on top using double-sided tape. In this test deposition, gold was used
for the working and counter electrode and silver for the reference electrode.
To achieve that, the cut-out for reference electrode or the cut-outs for the
working and counter electrodes are taped using Tesa Orange Masking Tape (RS
Components) as indicated in Figure 5.10 A) and Figure 5.10 B) respectively.
Figure 5.10: Representation of how to tape oﬀ the areas not to be exposed to metal
deposition.
The silicon wafer with the masking jig including the dummy substrate was
then placed in the electron beam evaporator and silver and gold were deposited
subsequently.
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5.5 Adapter
As explained in Section 5.2, the sensor has to be connected to the potentiostat.
An adapter was fabricated to connect the sensor to the DropSens connector
that is attached to the potentiostat as shown in Figure 5.4. For this purpose, a
standard one-sided FR4 copper substrate (Elite Material Co., Ltd) was used.
The design was purely based on ensuring to connecting the end-point of the
working counter and reference electrode to the electrical connection in the
connector as indicated by the colour coding in Figure 5.11.
Figure 5.11: Schematic drawing of the DropSens connector (left). Each colour-
coded connection of the sensor (right) connect to the colour-coded connection in the
DropSens connector.
Prior to the fabrication, a precise drawing was prepared using AutoCAD (Au-
todesk) (Figure 5.12 A), which was then transferred into the drawing software
InkScape to produce a mask (Figure 5.12 B) to be printed onto transparent
sheets. The in-house electrical workshop fabricated the PCB, using the pro-
vided mask. The printed-circuit boards (PCBs) (Figure 5.12 C) can potentially
be reused after having conducted measurements with them.
Figure 5.12: AutoCAD drawing of the adaptor. B) InkScape mask. C) Fabricated
adaptor fabricated from standard FR4 copper substrate.
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5.6 Characterisation Methods
In order to characterise the commercial and the fabricated electrodes, diﬀer-
ent imaging and measurement techniques were utilised. For the measurement
of surface height and roughness, a stylus proﬁlometer and white light inter-
ferometer were used. In addition to that, the surface was imaged using a
scanning electron microscope. Furthermore, the electrochemical surface area
of the commercial electrodes was determined electrochemically.
5.6.1 Optical and Mechanical
For the characterisation of the microneedles, commercial and fabricated elec-
trodes a white light interferometer and a stylus proﬁlometer have been utilised.
In a white light interferometer, a beam of a white light source is split into a
reference beam to be reﬂected by a mirror and a measurement beam to be
reﬂected by the sample. The system is adjusted so both beams travel the
same distances, so that an intensity interference fringing is generated, which is
utilised to create a proﬁle of the sample surface. The stylus proﬁlometer is also
used to measure proﬁle heights and surface roughness of a sample. However,
this proﬁlometer is a contact based method. A stylus is used to move across
the sample surface to recreate a two-dimensional map of the sample surface.
To have a more visual picture of the electrode surface a scanning electron mi-
croscope was used. In a scanning electron microscope, an electron beam is
aimed at the sample inside a vacuum chamber. The receiving signal reﬂect-
ing from the electrically conductive surface of the sample provides information
about the topography of the sample surface. In cases in which the surface of a
non-conductive material is observed with an SEM, the method is destructive
because it is necessary to deposit a conductive metal for the measurement. As
the substrates (microneedles and the PMMA sheet) are already coated with
conductive metal, the method is non-destructive.
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5.6.2 Electrochemical
The DropSens electrodes were analysed electrochemically by determining the
electrochemical surface area of the working electrode (WE) [22]. This is an
important step to ensure constant quality of the electrode surface. Therefore,
an electrochemical process has been established. It utilises cyclic voltamme-
try (CV) and chronocoulometry for the determination of the electrochemical
surface area. The electrochemical surface area is the area of an electrode at
which the electron exchange takes place. Therefore, the electrochemical sur-
face area is larger than the geometrical surface area due to the roughness of
the surface. If the diﬀusion coeﬃcient is known or if it can be estimated, only
CV is required and the electrochemical surface area, A, can be calculated from
rearranging the Randle Sevcik equation (Equation (5.1))[193]:
A =
slope
268600 · n2/3 ·D1/2 · C (5.1)
Where the slope is the
√
scanrate expressed in (
√
V/s), n the number of elec-
trons, C the concentration of the analyte in mol/cm3 and D the diﬀusion
coeﬃcient of the analyte (6.7 · 10−6 cm2/s) [22, 193].
If the diﬀusion needs to be determined prior to the calculation of the electro-
chemical surface area, chronocoulometry is performed additionally to the CV.
From the chronocoulometry the Anson plot is created by plotting the charge
against the square root of time from which the slope is calculated. The slope
is used to calculate the diﬀusion coeﬃcient:
D =
slope2
(268600 · C)2 (5.2)
Where C is the concentration in (mol/cm3). The diﬀusion coeﬃcient is then
used to calculate the electrochemical surface area by rearranging the Anson
equation [5]:
A =
a
2nFC ·D1/2pi1/2 (5.3)
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Where a is the slope of the Anson plot (charge over
√
time), n the number
of electrons, F the Faraday constant, C the concentration in mol/cm3 and D
the diﬀusion coeﬃcient (cm2/s) [22, 26]. With the calculated value for the
electrochemical surface area the roughness factor ρ can be calculated [22]:
ρ =
AEC
AG
(5.4)
Where AEC is the electrochemical surface area and AG the geometrical surface
area [22]. The characterisation procedure follows the following steps:
1. Chlorination of the reference electrode, to create a silver/silver-chloride
(Ag/AgCl) electrode from the plain silver electrode
2. Cleaning of the electrode system.
3. Preparation of the electrolyte solution.
4. Cyclic Voltammetry.
In this work, the electrochemical surface area is calculated using an estimated
value from the literature for the diﬀusion coeﬃcient (6.7 ·10−6 cm2/s) [22, 193].
Before the CV can be performed the RE is created by applying a 50 mM Iron
(III) Chloride Hexahydrate [FeCl3] onto the RE for 20 seconds before it is rinsed
with deionised water and dried with argon gas. Subsequently, the electrode
is cleaned by the deposition of a drop of sulphuric acid (0.1 M), followed by
cyclic cleaning. This is done to clean the electrodes from dust and roughen
the surface. The electrodes were then rinsing with deionised water and dried
with argon gas. The cyclic cleaning is conducted by the deposition of 0.1 M of
sulphuric acid, followed by cyclic voltammetry. The cyclic voltammetry was
run for 3 cycles. The parameters set in the potentiostat are summarised in
Table 5.5. The electrodes are then rinsed with deionised water and dried with
argon gas.
For the cyclic voltammetry, a 10 mM electrolyte solution of Potassium Fer-
rocyanide (K4(Fe(CN)6)) and Potassium Ferricyanide (K3(Fe(CN)6) was pre-
pared as a electron transfer agent. Firstly, a 100 mM solution of each com-
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Table 5.5: Parameters for cyclic cleaning for gold and platinum electrodes.
Parameter 1st 3 cycles 2nd 3 cycles
Start potential [V] 0.0 0.0
Upper vortex [V] 1.6 1.3
Lower vortex [V] 0.0 0.0
Stop potential [V] 0.0 0.0
Number of scans 3 3
Scan rate [V/s] 0.1 0.1
ponent was made, of which 1 ml of each was added to 8ml Phosphate Buﬀer
Saline (PBS). A drop of 100 µl was deposited onto the cleaned electrodes prior
to CV at scan rates of 10, 25 and 50 mV/s [22].
5.7 Results
This section provides the results for this chapter. Firstly, the electrochemical
analysis is presented followed by the determination of the electrochemical sur-
face area. Secondly, the results of the characterisation of the microneedles and
the fabricated electrode are shown. Lastly, the assembled sensor prototype is
presented.
5.7.1 DropSens Electrodes: Electrochemical Analysis
Initially, a basic characterisation of the electrode/electrolyte system was con-
ducted which also aided in the familiarisation with the electrochemical tech-
niques. The DropSens electrodes were analysed regarding their reversibility,
peak separation and peak current ratio (Chapter 2). The peaks and their po-
sitions were acquired from a voltammogram such as shown Figure 5.13. The
cyclic voltammogram was obtained from a cyclic voltammetry experiment in
10 mM ferro-/ferricyanite solution at three diﬀerent scan rates (0.01 V/s, 0.025
V/s and 0.05 V/s). This solution is only used for the intial electrochemical
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analysis of the DropSens electrodes. The ferro-/ferricyanite solution is used as
a electron transfer agent.
Figure 5.13: Representative cyclic voltammogram at three diﬀerent scan rates using
10 mM ferro-/ferricyanite solution.
The results of the peak separation and the peak current ratio are listed in
Table 5.6. The cyclic voltammograms at the diﬀerent scan rates are shown
in Figure 5.13. It can be seen that, although the voltammograms follow the
same shape, they diﬀer however in their magnitude. The higher scan rate, the
higher the current observed, which is in agreement with the literature [22]. The
average peak current ratio is 0.98 which indicates a reversible system as the
ideal value is 1 when receiving the same current (opposite algebraic signs) for
oxidation and reduction. The results for the peak separation give an average
value of 78.74 mV where the ideal value is 57 mV (Chapter 2). The oxidation
and reduction process is slightly lower than in an ideally reversible system,
however, a reason for this could be that the experiments were conducted at a
temperature between 19 - 21°C and not at a temperature of 25°C, for which
the ideal values are calculated. With peak current ratio suggesting a reversible
system and peak separation values that do not vary much from the ideal value,
it can be said that the system using the electrolyte solution is reversible. In
Figure 5.14 the CVs of gold (Au) electrodes and platinum (Pt) electrodes in
electrolyte solutions (10 mM ferro-/ferricyanite solution) at three diﬀerent scan
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rates (0.01, 0.025, 0.05 V/s) are compared. Each colour represents two cycles
at a speciﬁc scan rate using a diﬀerent electrodes for each scan rate. Higher
currents were detected for the Pt electrodes which are most likely due to the
larger geometrical surface area. The geometrical surface area of the Pt elec-
trode is 12.57 mm2 and the Au electrode 2.01 mm2. The current also increases
with increasing scan rate as expected. The peak currents of the Au and Pt
electrodes at diﬀerent scan rates are summarised in Table 5.7 and visualised in
Figure 5.16. The signal obtained from the blank solution (PBS) is compared to
the solution containing the electroactive species. It can be seen that a higher
current (20 times greater) was generated in the electrochemical cell with the
electroactive species present than in the blank solution (Figure 5.15).
Table 5.6: Scan rates, Peak separation and peak-current ratio for gold and platinum
electrodes10 mM ferro-/ferricyanide.
Electrode Scan Rate (V/s) Peak Sep. (mV) Peak current ratio
Au 1 0.01 75.68 1
0.025 83.01 1
0.05 87.89 1
Au 2 0.01 75.7 1
0.025 83 1
0.05 90.34 1
Average Au 82.60 1.00
Pt 3 0.01 73.25 1.1
0.025 80.57 1.1
0.05 78.13 0.9
Pt 4 0.01 68.36 0.9
0.025 73.24 0.9
0.05 75.68 0.9
Average Pt 74.87 0.97
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Figure 5.16: Comparison of peak currents at diﬀerent scan rates (0.01, 0.025, 0.05
V/s) for gold and platinum electrodes.
Table 5.7: Peak currents of two gold and two platinum electrodes at diﬀerent scan
rates.
Electrode Peak Current (µA)
Scan Rate (V/s) 0.01 0.025 0.05
Au1 25.2 41.3 58.8
Au2 25.3 37.1 50.1
Pt3 153 231 322
Pt4 151 230 313
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5.7.2 Electrochemical Surface Area
The electrochemical surface area was determined electrochemically by the
method described in Section 5.6.2 using cyclic voltammetry (CV). An example
of voltammograms taken at three diﬀerent scan rates is shown in Figure 5.13 in
Section 5.7.1, from which the peak currents are determined. These are plotted
against the square root of the scan rate, (Figure 5.17), providing the slope
required for the calculation of the electrochemical surface area. These graphs
were created for each measurement.
Figure 5.17: Peak current against the square root of the scan rate for the determi-
nation of the slope.
The Randle Sevcik equation was rearranged to calculate the electrochemical
surface area and the roughness factor, giving
A =
slope
268600 · n2/3 ·D1/2 · C (5.5)
Where the slope is determined from the peak current vs. square root of scan
rate plot (ip/
√
V/s) for each three scan rates, n is the number of electrodes
which is 1 for the electrolyte solution used, D the diﬀusion coeﬃcient (cm2/s)
obtained from the literature 6.3 · 10−6 cm2/s and C the concentration of the
electrolyte solution (mol/cm3). The results of the measurements are shown in
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Table 5.8.
Table 5.8: Results of the electrochemical surface area of uncleaned platinum elec-
trodes. ECSA = electrochemical surface area, GSA = geometrical surface area.
Electrode CV Slope ECSA (mm2) GSA (mm2) Roughness Factor
Pt1 0.0009 13.3 12.57 1.062
Pt2 0.0011 16.3 12.57 1.298
Pt3 0.001 14.8 12.57 1.180
Pt4 0.0011 16.3 12.57 1.298
Pt5 0.0012 17.8 12.57 1.416
Pt6 0.0012 17.8 12.57 1.416
Table 5.9: Results of the electrochemical surface area of cleaned platinum and gold
electrodes. ECSA = electrochemical surface area, GSA = geometrical surface are.
Electrode CV Slope ECSA(mm2) GSA (mm2) Roughness Factor
Pt1 0.0015 22.25 12.57 1.770
Pt2 0.0014 20.77 12.57 1.652
Pt3 0.0015 22.25 12.57 1.770
Pt4 0.0015 22.25 12.57 1.770
Pt5 0.0015 22.25 12.57 1.770
Pt6 0.0015 22.25 12.57 1.770
Pt7 0.0014 20.77 12.57 1.652
Pt8 0.0013 19.28 12.57 1.534
Au1 0.0003 4.45 2.01 2.214
Au2 0.0002 2.97 2.01 1.476
Table 5.8 shows the results for the electrochemical surface area for electrodes
that have not been treated with cyclic cleaning before the measurements. Both
tables (Table 5.8 and Table 5.9), give the result of the slope obtained from the
CV, the electrochemical surface area (ECSA) calculated from the rearranged
Randle Sevcik equation, the geometrical surface area (GSA) and the roughness
factor which was calculated by dividing the ECSA by the GSA.
Table 5.9 lists the results of cleaned electrodes. The electrochemical surface
area of the uncleaned electrodes is almost equal to the geometrical surface
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area of 12.57 mm2. The electrochemical surface area of cleaned Pt electrodes
is almost twice as large. It is apparent that cleaned electrodes exhibit a greater
electrochemical surface area than untreated equivalents. These results support
the eﬀectiveness of the cleaning process, making the surface clean and rougher
and therefore enhancing the electrochemical surface area. The determination
the electrochemical surface area of commercial Au electrodes exhibits the same
trends. The electrochemical surface area of cleaned Au electrodes is larger than
its geometrical surface area. Similar results have been obtained by Fragkou et
al. [22] who have determined the electrochemical surface area of screen-printed
electrodes and found it to be three times as large as the geometrical surface
area [22].
5.7.3 Microneedles and PMMA electrodes
For the purpose of an initial quality control of the purchased microneedle
arrays and for retrospective analysis to gauge the success of the fabrication
process, optical microscope images were taken before the modiﬁcation of the
microneedle array introduced in Section 5.3.1. A representative image is shown
in Figure 5.18 (A)). From the image with high magniﬁcation (Figure 5.18
(B)) a closer portion of the area is shown. As the focus of the image is on
the surface and not on the microneedle, the microneedle itself is not visible
(black square). In these images, the microneedles appear to be cuboid-shaped.
However, the tips of the microneedles are not accurately represented in these
images.
Figure 5.18: MicroPoint microneedle images using the dice wafer cutter imaging
capabilities at a "Low" (A)) and "High" (B)) magniﬁcation.
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However, the Dino-Lite images taken suggest that the microneedles have the
shape of a square-based pyramids. Therefore, a scanning electron microscope
image was taken. The image is presented in Figure 5.19 C) clearly shows a
pyramidal shape. The characterisation also conﬁrmed the dimensions of the
microneedle arrays (Table 5.1).
Figure 5.19: Dino-Lite images of microneedle array (A) and B)) and scanning
electron microscopy image of one microneedle (C)).
The result of the silver deposition (manual tape masking) onto the microneedle
array is shown in Figure 5.20. The pictures were taken using a Dino-Lite
camera. From these pictures, no notable diﬀerences in the silver surface at
diﬀerent locations in the array were observed.
Figure 5.20: Deposition of silver onto the microneedle array. A) Top view. B)
Front view.
A clear distinction between the deposited and un-deposited rows of needles
is observed. However, as the maneuvering of the PTFE tape over the mi-
croneedle was challenging, the edges do not show a clear straight distinction
between the coated and uncoated area. Furthermore, it becomes apparent
that the upper row of the left-hand silver deposition in Figure 5.20 is smaller
than the lower row. These inaccuracies can be attributed to the problematic
masking method using the PTFE tape. In addition to the observation of the
silver deposition with the Dino-Lite camera, the results were also examined
using a scanning electron microscope (SEM). Figure 5.21 A) and B) show the
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image of the microneedle array at the position indicated by the red circle in
Figure 5.21 C) at 50 x magniﬁcation. The brighter area on the left-hand side
represents the silver deposition and the darker area, on the right-hand side, is
the microneedles without silver deposition. From these images, a distinction
can be made between the metal and non-metal area on the microneedle array.
Figure 5.21: Scanning electron microscope image of the microneedle array at the
position indicated by the red circle from the view indicated by the arrow.
By increasing the magniﬁcation further, it becomes apparent that the tips of
the microneedles are slightly bent in a range of 30 µm Figure 5.22. Although
not all tips were bent, both coated and uncoated microneedles exhibited the
same bending. This could be caused by either the heat the microneedle array
was exposed to in the chamber of the electron beam evaporator or by the metal
tweezers with which they were handled during the characterization procedure.
Plastic tweezers were then used to reduce the risk of bending. To reduce the
inﬂuence of the heat in the vacuum chamber a heat sink can be applied to
reduce the heat radiation for the microneedles.
Figure 5.22: Scanning electron microscope images of two single coated (Ag) mi-
croneedles of the microneedle arrays at a A) 398x magniﬁcation and B) 465 x mag-
niﬁcation.
Overall, the electron beam deposition technique can be seen as compatible
with the deposition of metals onto PMMA microneedle array. However, the
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masking technique utilising the manual application of PTFE tape was proven
not only to be time-consuming but also problematic, as some microneedles
showed bending of the tips. Therefore, the masking technique using the PMMA
masks should be used. Additionally, the microneedle should be handled with
plastic tweezers instead of metal tweezers to prevent damage.
To prevent deformation due to heat impact in the electron beam evaporator,
a heat sink within the vacuum chamber can be installed.
5.7.4 Dummy electrode on PMMA
Following the time-consuming masking method with PTFE tape, a PMMA
sheet (dummy substrate) was utilised as described in Section 5.4. In this
section, the results of the metal deposition are presented. Figure 5.23 shows
the resulting electrode, using a Dino-Lite camera. The pictures show a three-
electrode system deposited onto the PMMA sheet. For the working (middle)
and counter electrodes (left), gold was deposited and silver for the reference
electrode (right)(Figure 5.23).
Figure 5.23: Images of deposited three-electrode cell onto PMMA using the electron
beam evaporator. Working electrode and counter electrode: gold, reference electrode:
silver. A) Side view B) Front-top view.
This new masking method has the advantage of providing some protection
against heat and a more precise application of the pattern onto the substrate.
From the Dino-Lite images in Figure 5.23, the distinction between the metal
and the PMMA is clearly delineated. Dino-Lite images at higher magniﬁcation
were taken, as shown in Figure 5.24. The area that they were taken from is
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indicated by the colours. There is a clear separation between the three diﬀerent
electrodes ensuring that there is no unwanted electrical short circuit.
Figure 5.24: Close-up Dino-Lite images of the edges of the metal deposition.
An SEM image of the separation between the electrodes was also taken. A
representative image is shown in Figure 5.25. The image shows a 299-times
magniﬁcation of the indicated area of the electrode. From the SEM, a clear
separation is diﬃcult to see.
Figure 5.25: Scanning electron microscopy image of the electrode edges.
This is most likely due to the problem of edge eﬀect found in SEM imaging
[194]. As the outside edges of a deposited surface are slightly greater in height
than the rest of the surface as shown in the schematic drawing in Figure 5.26.
Edges and points generate more electrons when hit with the electron beam in
an SEM. Therefore, the gap between the metal deposition and the unexposed
PMMA seems smaller than it actually is, due to a larger number of electrons
emitted from the surface.
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Figure 5.26: Cross-section of the PMMA sheet with the metal deposition.
In addition to the Dino-Lite images, the roughness of the PMMA electrodes
was analysed and compared to the roughness of the commercial DropSens
electrodes. As explained in Section 5.6.2, a rougher surface provides more
sites for the enzyme to attach to when immobilised onto the electrode surface.
For these measurements, a Zygo white light phase shifting interferometer was
utilised, as outlined in Section 5.6.1. The roughness was measured over a
length of 1 mm and 3 mm. The roughness of the PMMA electrode was found
to be 735.84 Å compared to 10,300 Å for a DropSens electrode. These results
show that the fabricated electrode has a very smooth surface compared to the
DropSens electrode, which has a rougher surface. This was expected as the
substrate used (PMMA sheet) is transparent and has a plain surface. These
results are summarised in Table 5.10. Each value represents one measurement.
Table 5.10: Results for electrode roughness using a Zygo white light interferometer.
Electrode Roughness
Scan range 1 mm 3 mm
DropSens electrode 10,300 11,000
PMMA electrode 297.74 735.84
The increase in roughness of the fabricated electrode when measuring over a
larger length is due to the irregularities, such as dust enclosed by the metal
deposition. These are represented by the red peaks in the images of the sur-
face produced by the white light interferometer. The representation of the
DropSens electrode generated by the white light interferometer is shown in
Figure 5.27.
For a clearer imaging of the electrode surfaces, the electrodes were examined
under a scanning electron microscope as shown in Figure 5.28. On the left-hand
side of Figure 5.28, an image of the fabricated PMMA electrode (uncleaned)
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Figure 5.27: Topographic map of A) PMMA working electrode and B) DropSens
electrode.
in comparison to the DropSens electrode (Figure 5.28 (right))is shown at a
magniﬁcation of 5000-times. Apart from a few spherical imperfections, the
surface is smooth. The image of a DropSens electrode, however, shows a
rougher surface as previously measured. For enzyme immobilisation, as also
applied in this project (Chapter 6) a rougher surface provides more sites for
the enzyme to attach to.
Figure 5.28: SEM images of the PMMA working electrode (uncleaned) (A)) and a
DropSens working electrode (B)) and their respective surface roughness.
Since rougher surfaces oﬀer both a larger electrochemical area and more sites
for enzyme immobilisation, it was therefore tested to roughen the surface prior
to the application of the metal layer. For this purpose, the raw PMMA squares
were subjected to lapping, where one surface of the PMMA square is rubbed
against a rotating disc covered in a lapping slurry, which then abrades the sur-
face. Initial results for the lapping of PMMA squares are listed in Table 5.11.
An images of the lapped PMMA sheet are shown in Figure 5.29 A)and is com-
pared to unlapped PMMA sheet in Figure 5.29 B). The PMMA sheets were all
lapped in the same session for the same duration. However, the received rough-
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ness diﬀers signiﬁcantly from each other, which suggests that improvement of
the lapping process is necessary especially with regards to the attachment of
the PMMA sheet to the attachment ﬁxture and the position of the PMMA on
the glass wafer.
Table 5.11: Surface roughness of lapped PMMA sheets in comparison to the working
PMMA electrode and the DropSens working electrode and substrate roughness.
Surface PMMA Sheet PMMA electrode DropSens
1 2 3 WE WE Substrate
Roughness (Å) 12,859 5,503 6,248 297 10,300 866
Figure 5.29: A) Photograph of lapped PMMA square compared to an unmodiﬁed
PMMA sheet (B)).
5.7.5 Assembled Sensor
After the fabrication of the adapter as outlined in Section 5.2, this component
was tested for compatibility with the DropSens connector. As illustrated in
Figure 5.30 the adaptor ﬁts into the connector regarding all dimensions. Also,
the copper line connects to the connection inside the connector as planned.
Note, there are diﬀerent connectors available. The connector shown in Fig-
ure 5.30 has four contacts to use a electrode including two working electrodes.
This connector was utilised to determine the compatibility of the fabricated
adapter with the connector.
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Figure 5.30: Adapter in DropSens connector.
The sensor was then assembled as shown in Figure 5.31. The PMMA electrode
is attached to the PCB adaptor using double-sided tape. The electrical connec-
tion between the working, counter and reference electrode and the respective
copper lanes on the PCB were established using conductive silver paste. How-
ever, the sensor was not utilised for any electrochemical experiments.
Figure 5.31: Assembled three-electrode sensor with gold used for the working and
counter electrode and silver for the reference electrode.
5.8 Conclusions
The purchased DropSens electrodes were characterised using the basic elec-
trochemical method cyclic voltammetry. The results showed that the elec-
trode system (electrode and electrolyte used) is reversible and that higher
currents were obtained from platinum electrodes, which may be due to the
larger geometrical surface area of the platinum electrodes. Furthermore, the
electrochemical surface area of the commercial electrodes was determined by
applying cyclic voltammetry and solving the Randle Sevcik equation for the
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electrochemical surface area. It was found that the electrochemical surface can
be as much as twice as large as the geometrical surface, which is attributed
to the surface roughness of the electrode surface. The microneedles purchased
from MicroPoint were then characterised and tested for modiﬁcation using
the electron beam evaporator. After ensuring that the microneedle arrays are
compatible with the electron beam deposition utilising PTFE for masking,
a new masking method was developed to avoid the time-consuming masking
with which only simple geometries such as stripes can be created. This was
achieved by using a mask later-cut from PMMA and a PMMA jig to hold the
sample in place. The results show, that the three-electrode pattern was de-
posited utilising the electron beam evaporator successfully. A dummy sensor
was assembled attaching the PMMA sheet onto an adapter fabricated from
standard FR4 copper substrate. It was ﬁnally shown that the sensor has been
developed successfully to ﬁt the geometries of the DropSens connector, which
is used to connect sensor electrode to the potentiostat for measurements.
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6 Immobilisation
This chapter provides the protocols for the preparation of the electrodes and
the following immobilisation of lactate oxidase applying covalent bonding and
cross-linking. For these experiments, the commercial DropSens electrodes
(gold and platinum) were used. The aim of this chapter is to identify the most
eﬀective immobilisation method, which is characterised by the subsequent elec-
trochemical performance utilising electrochemical impedance spectroscopy. All
work presented in this chapter and in Chapter 7 has been conducted at the
Devision of Infection and Pathway Medicine (DIPM) at the University of Ed-
inburgh under the supervision of Dr. Till Bachmann and Dr. Holger Schulze.
The protocols in this chapter were adapted from immobilisation protocols for
immobilisation provided by DIPM.
6.1 Electrode Preparation
The electrodes are prepared prior to the functionalisation of the working elec-
trode (WE). Firstly, the reference electrode (RE) is created by applying a 50
mM Iron (III) Chloride Hexahydrate [FeCl3] onto the RE for 20 seconds before
it is rinsed with deionised water and dried with argon gas. Subsequently, the
whole electrode system is cleaned by the deposition of 0.1 M of sulphuric acid,
followed by cyclic voltammetry. The cyclic voltammetry was run for 3 cycles
twice to clean the electrodes from dust and roughen the surface. The param-
eters set in the potentiostat are summarised in Table 6.1. The electrodes are
then rinsed with deionised water and dried with argon gas.
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Table 6.1: Parameters for cyclic cleaning for gold and platinum electrodes.
Parameter 1st 3 cycles 2nd 3 cycles
Start potential [V] 0.0 0.0
Upper vortex [V] 1.6 1.3
Lower vortex [V] 0.0 0.0
Stop potential [V] 0.0 0.0
Number of scans 3 3
Scan rate [V/s] 0.1 0.1
6.1.1 Cross-linking
This section provides the protocol for the cross-linking process. The reagents
and chemicals required for this are summarised in Table 6.2.
Table 6.2: Chemicals/reagents used for cross-linking and purchase origin.
Chemical Function Company
(Country)
Hydroxyethyl Cellulose (HEC) Gelling thickening agent Sigma-Aldrich
to provide a matrix for Lox (UK)
Lactate Oxidase (Lox) Recognition Element Sorachim
(CH)
Bovine serum albumin (BSA) Improve stability Sigma-Aldrich
(UK)
Glutaraldehyde (GA) Cross-linking Sigma-Aldrich
(UK)
Phosphate Buﬀer Saline (PBS) Buﬀer to make solutions Sigma-Aldrich
(UK)
This immobilisation process consists of three steps:
1. the preparation of the HEC- Lox solution;
2. the preparation of the BSA solution;
3. the curing of HEC-Lox-BSA composition in Glutaraldehyde vapour.
A 1% hydroxyl cellulose (HEC) solution was prepared by dissolving 1 g of HEC
in 100 ml PBS. 100 µl of the HEC solution was then used to dissolve 2 mg
Lox which was kept on ice until used. Following that, a 5% BSA solution was
prepared by adding 1 µl BSA (50mg/ml) to 9 µl PBS, which was then added
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to the HEC/Lox solution. This solution was deposited on the electrode using a
pipette, which is then exposed to glutaraldehyde vapour for 30 minutes. This
was done by carefully pouring glutaraldehyde into a small beaker under the
fume hood, then placing the beaker into a plastic container. The electrodes
were placed into the same container next to the beaker, after which its lid was
closed. Subsequently, the electrodes were left to dry at room temperature for
1 hour, which ﬁnalised the immobilisation process.
6.1.2 Covalent Binding
In this section, the protocol for the covalent bonding process is introduced.
The reagents and chemicals required for this are summarised in Table 6.3.
Table 6.3: Chemicals/reagents used for covalent bonding and purchase origin. Sulfo-
LC SDPD =(Sulfosuccinimidyl 6-(3'-(2-pyridyldithio)propionamido)hexanoate),
TCEP = Tris(2-carboxyethyl)phosphine hydrochloride.
Chemical Function Company
(Country)
Sulfo-LC SDPD Bifunctional crosslinker to add Sigma-Aldrich
thiol group for immobilisation (UK)
Lactate Oxidase (Lox) Recognition Element Sorachim (CH)
DL-Dithiothreitol (DTT) Created free thiol group Sigma-Aldrich
TCEP on bifunctional crosslinker (UK)
Saturated Potassium To create humid environment Sigma-Aldrich
Chloride (UK)
Phosphate buﬀer Buﬀer to make solutions Sigma-Aldrich
saline (PBS) (UK)
This immobilisation process for covalent bonding consists also of three steps:
1. the preparation of the Sulfo-LC SDPD - Lox solution;
2. the preparation of the DTT solution;
3. the incubation of HEC-Lox-BSA composition in at a high humidity en-
vironment (approximately 85% relative humidity).
Firstly, a 40 mM Sulfo-LC SDPD solution was prepared by dissolving 4 mg
Sulfo-LC SDPD in 189 µl PBS. 20 µl of the 40 mM Sulfo-LC SDPD solution
was then used to dissolve 2 mg Lox which was then incubated at room tem-
perature for one hour. Meanwhile, a 150 mM DTT solution is prepared of
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which 20 µl is added to the Lox / Sulfo-LC SDPD solution. This DTT/ Lox /
Sulfo-LC SDPD solution was incubated for another hour at room temperature
before its deposition onto the electrodes, followed by an incubation at high
humidity at 4°C for 2 hours. This is achieved by placing the electrode into
a box containing saturated potassium chloride (KCl) solution, which is then
placed into refrigeration.
6.2 Characterisation:
Electrochemical Impedance Spectroscopy
Electrochemical Impedance Spectroscopy (EIS) measurements were conducted
in order to determine the success of the immobilisation. In EIS, small sinusoidal
potentials (2 - 10 mV) of a frequency range such as 100 kHz - 0.3 Hz are
applied to the electrochemical cell. The electrochemical response is measured,
the impedance is calculated from that response and plotted for analysis either
as a Bode Plot or a Nyquist Plot. The impedance is the sum of the imaginary
and the real impedance and represents a complex form of Ohm`s law:
Z(jω) =
U(jω)
I(jω)
= ZRe(ω) + jZIm(ω) (6.1)
Where Z is the impedance, U the voltage, I the current, ZRe the real impedance,
and jZIm the imaginary impedance. The radial frequency ω = 2pif with f as
the frequency. A typical EIS Nyquist plot is shown in Figure 6.1 (left-hand
side). It consists of a semi-circle and linear part with the real impedance on
the x-axis the imaginary impedance on the y-axis. The Nyquist diagram is
plotted from high frequencies to low frequencies as indicated in Figure 6.1
(left-hand side). The three main values that can be acquired from the Nyquist
plot are Rs (resistance of the solution), Ret (electron transfer resistance) and
Zw (Warburg resistance).
Figure 6.1 (right-hand side) represents the Nyquist plots of a bare electrode
(blue graph) and electrode which had undergone an immobilisation process
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Figure 6.1: Typical Nyquist plot with an imaginary impedance on the y-axis and
the real impedance on the x-axis. The frequency increases from right to left (left-hand
side). Visualisation of the diﬀerence in Nyquist plots with and without a substance
immobilised on the electrode surface (right-hand side).
(yellow graph). It can be seen that Rs (solution resistance) is the same whereas
the electron transfer resistance (Ret) increases from Ret1 to Ret2, for the func-
tionalised electrode. Therefore, by determining the Ret value the success of
the immobilisation process can be accessed [195].
6.3 Results
Results include measurement of blank DropSens electrodes in hydrogen perox-
ide (H2O2), a by-product of the reaction between lactate oxidase and lactate,
as explained in Section 4.3.1. Additionally, the results of the amperometric
lactate measurements using functionalised electrodes are provided. Compari-
son of the two immobilisation methods, covalent bonding and cross-linking, is
carried out. These measurements are conducted on both gold and platinum
electrodes. Electrochemical impedance spectroscopy (EIS) was utilised to de-
termine the success of the immobilisation. The follwing results are shown in
the sections below:
1. Cyclic Voltammetry in H2O2 and lactate solution.
2. Initial amperometric measurements using functionialised electrodes in
lactate solution.
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3. Electrochemical impedance spectroscopy (EIS) measurements.
6.3.1 Cyclic Voltammetry
Figure 6.2 shows the result of one CV of a blank Au electrode in 3% H2O2
solution. The overpotential is equal to the position of the oxidation peak
and is 670 mV (red dotted vertical line). The overpotential is utilised for the
amperometric measurements in Section 6.3.2. A potential range of -0.2 - 0.8
V was scanned.
Figure 6.2: Cyclic voltammogram of a blank gold electrode in 3% hydrogen peroxide.
Cyclic voltammetry is also performed on a gold electrode that has lactate oxi-
dase cross-linked and covalently bonded onto their working electrode. For the
measurement, a 10 mM lactic acid solution was applied to each electrode (the
whole three-electrode system is covered). Cyclic voltammetry was performed
in the range of -0.2 V to 0.8 V at a scan rate of 0.1 V/s. The results for one
measurement for each electrode are presented in Figure 6.3 and Figure 6.4. For
the electrode with lactate oxidase cross-linked onto the surface (Figure 6.3) a
small oxidation peak was obtained at 670 mV ((red dotted vertical line) as
previously measured with the blank electrode in H2O2 solution. The fact that
the oxidation peak is so small is indicative of either an inactivity of the Lox
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or a low concentration of Lox applied to the WE.
Figure 6.3: Cyclic voltammogram: Gold electrode with cross-linked lactate oxidase
10 mM lactic acid solution.
The oxidation peak for the gold electrode with lactate oxidase covalently
bonded onto the electrode surface is more distinct as presented in Figure 6.4.
CV was performed between -0.2 V and 0.8 V at a scan rate of 0.1 V/s. As
expected from the previous measurement (Figure 6.2), the overpotential is at
670 mV. The oxidation is also an indication of lactic acid being oxidised, gen-
erating a current of approximately 1.5 µA. The peaks at 0.7 V and 0.8 V are
due to the additional evolution of hydrogen and can therefore be ignore for the
determination of the overpotential.
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Figure 6.4: Cyclic Voltammogram: Gold Electrode with Covalently bonded Lactate
Oxidase 10 mM lactic acid solution.
6.3.2 Amperometric Measurements
Following the cyclic voltammetry (Section 6.3), amperometric measurements
were conducted using the overpotential of 670 mV obtained from the cyclic
voltammograms. Prior to application of the potential, only PBS was deposited.
After the equilibrium was reached (for a current of less than 0.05 µA), 10 µl of
a 100 mM lactic acid solution was added to the buﬀer. Each of the following
graphs represents the results of one measurement. The resulting currents for
the electrode with cross-linked and for covalently bonded lactate oxidase are
presented in Figure 6.5 and Figure 6.6 respectively.
The amperometric measurement of the cross-linked lactate oxidase (Figure 6.5)
does not show a current response upon the application of lactic acid to the elec-
trode. This correlates with the results received from the cyclic voltammetry
measurements presented in Section 6.3. It is most likely that the enzyme lac-
tate oxidase was inactivated during the immobilisation process or that the
bovine serum albumin (BSA) is blocking the electrode surface, preventing ox-
idation. From the amperometric measurement of the electrode with the cova-
lently bonded lactate oxidase (Figure 6.6), a current response of 0.5 µA was
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Figure 6.5: Amperometric measurement: Gold electrode with cross-linked lactate
oxidase 100 mM lactic acid solution.
measured. The red arrow in the graph indicates the application of the lactic
acid solution. It can be seen that, upon the application of the lactate acid
solution, that the current increases until it reached its peak at about 0.5 µA.
The current then decreases over a period of approximately 20 seconds. This is
due to the exhaustion of lactic acid which is fully oxidised.
Figure 6.6: Amperometric Measurement: Gold Electrode with covalently bonded
lactate oxidase 100 mM lactic acid after equilibrium was reached.
As can be seen from the two amperometric measurements above, when a lactate
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solution is applied to an electrode with covalently bonded enzymes on the
working electrode current response of 0.5 µA was observed. No response with
the electrode for which cross-linking was utilised as means of immobilisation
was detected. One reason may be that stabilisation reagent bovine serum
albumin was blocking the electrode transfer electrodes resulting in no current
response. However, it is also possible that the enzymes were deactivated during
the immobilisation process. This would lead to the same result and no lactate
is metabolised. These initial experiments indicate that covalent bonding may
have been more successful than cross-linking for the enzyme lactate oxidase.
Further experiments are required to prove repeatability.
6.3.3 EIS Measurements
Electrochemical impedance spectroscopy (EIS) was performed, as introduced
in Section 6.2, in order to characterise the immobilisation. The covalent bond-
ing protocol presented in section Section 6.1.2 was applied for the immobilisa-
tion of lactate oxidase. Firstly, DL-Dithiothreitol DTT was used as described
in the protocol. The solution was incubated on the electrodes overnight. Sam-
ples included three platinum (Pt) and three gold (Au) electrodes and one
control electrode without the enzyme.
Figure 6.7: Schematic representation of a EIS Nyquist plot.
For the measurement, a 10 mM ferro-/ferricyanide solution was applied to the
electrodes before the EIS measurements. The electrochemical system was set
to a potential of 10 mV and 20 frequencies in the range of 100 kHz to 0.3 Hz
were recorded. From the EIS measurements the value Ret, which represents the
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electron transfer resistance (Figure 6.7), is determined to assess the success of
the immobilisation process. The results are shown in Figure 6.8 and Figure 6.9.
Figure 6.8: DTT overnight incubation on platinum electrodes. NC = negative
control. Ret = electron transfer resistance.
Figure 6.8 shows the results of three (and the negative control (NC)) EIS
measurements for the platinum electrodes. The lowest impedance was observed
for the control (180 Ohms) as expected.
The other three electrodes exhibit higher impedance (310 - 950 Ohms) due to
the immobilisation of the enzyme onto the working electrode. For the three
measurements presented the average resistance is 541 Ohms with a standard
deviation of 361 Ohms (Table 6.4). These initial results provide a proof of
concept that the immobilisation of lactate oxidase on platinum electrodes was
successful, despite the high standard deviation.
Figure 6.9 the EIS measurement results of the gold electrodes are presented.
Again, the lowest impedance was received for the negative control electrode
(11 kOhms). The electrodes that have lactate oxidase immobilised on them
show a higher impedance (61 kOhms - 69 kOhms). The resistance measured
for electrode 1 is as low as the negative control, which suggests that the immo-
bilisation was unsuccessful due to enzyme deactivation. The average resistance
measured for the three electrodes was 63.47 kOhms with a standard deviation
of 31.34 kOhms. Despite the high standard deviation these preliminary results
show that lactate oxidase was immobilised onto the electrode surface. As the
results only show initial proof that the immobilisation was successful but still
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Figure 6.9: DTT overnight incubation on gold electrodes. NC = negative control.
Ret = electron transfer resistance.
show anomalies, further analysis of the immobilisation is required to show that
the results are repeatable.
Table 6.4: Average and Standard deviation of EIS measurements. n=Number of
electrodes.
Electrode n Average resistance (kΩ) Standard Dev. (kΩ)
Platinum 3 0.541 0.361
Gold 3 63.47 3.78 (excl. sample 1)
Table 6.4 provides a comparison of the resistance values obtained from the
platinum electrodes and the values measured from the gold electrodes. The
impedance value for the gold electrodes is higher by two orders of magnitude,
which suggests that the immobilisation is more eﬀective on the gold electrode
than on the platinum electrodes. However, it could also mean that the reagents
used stick to the gold surface more than to the platinum surface as the EIS
measurement does not distinguish between enzyme on electrode and reagents
on electrode. Amperometric measurements will conﬁrm the presents of the
enzyme and therefore the success of the immobilisation.
Additionally, Tris (2-carboxyethyl) phosphine hydrochloride (TCEP), an al-
ternative reagent to DTT, was tested. The same immobilisation protocol as
described in Section 6.1.2 was used, while DTT was exchanged for TCEP.
The lactate oxidase solution was incubated for one hour. The measurement
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Figure 6.10: DTT and TCEP after one- hour of incubation on gold electrodes in
1 mM ferro-/ferri cyanide. DTT NC = negative control for DTT, TCEP NC =
negative control for TCEP.
procedure remained as described above. These results are compared to the
immobilisation with DTT and are presented in Figure 6.10 and Figure 6.11.
Figure 6.11: DTT and TCEP after 1 hour of incubation on platinum electrodes 1
mM ferro-/ferri cyanide. DTT NC = negative control for DTT, TCEP NC= negative
control for TCEP.
Each bar represents one measurement. Successful immobilisation was achieved
after an hour of incubation using DTT. Figure 6.10 (please note the graph
is shown in a logarithmic scale) shows the EIS measurement results of gold
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electrodes comparing the immobilisation of DTT with TCEP (each bar repre-
senting one measurement on one electrode). The impedance for both negative
controls are low which shows that there was no contamination. The immobil-
isation with DTT exhibits a high impedance of 23.45 kOhms. However, the
impedance measured for the electrode on which TCEP was used to immobilise
the electrode shows a low impedance of 27.57 Ohms, a three orders of magni-
tude diﬀerence. This result shows that the immobilisation on gold electrodes
using TCEP was not successful.
The same measurements were conducted on platinum electrodes (Figure 6.11)(each
bar representing one measurement on one electrode). The negative control is
low, suggesting no contamination has taken place during the immobilisation
process. The immobilisation using DTT as described was also successful on the
platinum electrodes. Using TCEP instead of DTT shows a lower impedance
value but is distinctively higher than the control (TCEP NC) indicating that
the immobilisation worked. Based on these results, DTT was used for all
further measurements.
In addition to the above experiments, the incubation time was explored further.
Both platinum and gold electrodes were incubated overnight and compared
to the data obtained from the one-hour incubation. Figure 6.12 shows the
results of the measurements on gold electrodes (each bar representing one
measurement on one electrode). The incubation overnight resulted in higher
impedance indicating it is more successful. The impedance obtained from
the overnight incubation is at least four-fold higher compared to the one-hour
incubation.
The same experiment was performed using platinum electrodes. The results
of the overnight incubation were compared to the one-hour incubation. The
results of the EIS measurements are shown in Figure 6.13. The values are three-
fold lower compared to the impedance values obtained from gold electrodes.
However, for the platinum electrodes, the electrode that was incubated for only
one hour exhibits a much higher impedance value. In addition, the impedance
for the overnight control electrode exhibits a high impedance of 7,954 Ohms
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Figure 6.12: Comparison of overnight (ON) incubation versus one-hour incubation
on DropSens gold electrodes. NC = negative control.
which is higher than some of the positives. This is indicative of a contamination
of the control electrode. Due to the lack of repetitions of the measurements
more experiments are required to provide representative data.
Figure 6.13: Comparison of overnight (ON) incubation versus one-hour incubation
on DropSens platinum electrodes.
6.4 Conclusions
Initially, cyclic voltammetry was conducted on bare and functionalised DropSens
electrodes for the determination of the overpotential. This overpotential was
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utilised for initial amperometric measurements, which showed that using co-
valent bonding lactate oxidase is more successful than cross-linking. Electro-
chemical impedance spectroscopy was applied to characterise the immobilisa-
tion success. An alternative reagent to DTT, TCEP, and the duration of the
incubation time were also examined. Better immobilisation was achieved us-
ing DTT. On gold, longer incubation times resulted in better immobilisation.
The platinum electrodes exhibited better immobilisation results after only one
hour. Based on these limited number of tests, the impedance measured from
gold electrodes was much higher than on platinum electrodes. However, more
experiments are necessary for more concrete conclusions. The amperometric
measurements presented in Chapter 7 will provide more information about
the immobilisation success by measuring lactate concentration. This will give
insight in the enzyme activity on the electrode surface. These were initial ex-
periments. For more representative results, a higher number of repetitions is
required.
114
7 Amperometric Measurements
This chapter provides details about the amperometric measurements of H2O2
and lactate and the respective current responses. For all experiments, DropSens
gold and platinum electrodes were used. Firstly, H2O2 measurements utilis-
ing blank gold and platinum electrodes were performed. Next, functionalised
electrodes were used for amperometric measurements of a lactate solution,
and ﬁnally, an additional experiment regarding the storage capabilities of the
functionalised electrodes was conducted.
7.1 H2O2 Measurements
The H2O2 measurements can be divided into three experiments. Firstly, the
same concentration of H2O2 was applied to gold and platinum electrodes and
the resulting current at diﬀerent potentials was measured. Secondly, two dif-
ferent potentials for platinum and gold respectively were tested. After adding
a PBS buﬀer and the respective potential was applied, a 1.5% H2O2 solu-
tion is added subsequently. The current response to each addition of H2O2
was observed over a duration of two minutes. DropSens electrodes (gold and
platinum), as described in Section 5.1, were used for all measurements.
7.1.1 1st H2O2 Experiment
This experiment was conducted to observe the inﬂuence of the potential to
the resulting current when the concentration remains unchanged. Following
the preparation of the electrodes (creating the reference electrode and cleaning
the whole electrode), as described in Section 6.1, a 1.5% H2O2 solution was
prepared from a 30% H2O2 stock solution by diluting 50 µl of the H2O2 stock
solution with 950 µl PBS. 60 µl PBS is applied to the electrodes once the
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electrodes are connected. The required potential is set and the measurement
is started. The diﬀerent potentials that were tested in this experiment are
summarised in Table 7.1. Following the activation of the potentiostat, 30 µl
of lactate solution was added to the 60 µl of PBS on the electrode. Each
measurement was performed for two minutes.
Table 7.1: Potentials for gold and platinum electrodes used for H2O2 experiments.
Gold Platinum
500 mV 170 mV
700 mV 300 mV
550 mV
7.1.2 2nd H2O2 Experiment
This experiment is a continuous measurement of the resulting currents of gold
and platinum electrodes. The electrodes were prepared as explained in Sec-
tion 6.1 and a 1.5 % H2O2 solution was prepared. The current of the gold and
platinum electrodes were measured at 654 and 415 mV, respectively. These
values were determined through cyclic voltammetry (current peak). Before the
measurements, 60 µl of PBS was added to the electrode. After the respective
potential was applied, 10 µl of the H2O2 solution was applied repeatedly af-
ter the previous response was observed. The time evolution of the resulting
current was recorded for six minutes.
7.1.3 3rd H2O2 Experiment
In this experiment, the current responses to diﬀerent H2O2 concentrations were
observed. The potential for the gold electrode was set at 420 mV and 153 mV
for the platinum electrode. H2O2 solutions at diﬀerent concentrations were
achieved by diluting the stock solution using PBS. The concentrations used
for this experiment are listed in Table 7.2. Each measurement was conducted
separately for three minutes and the electrodes were cleaned by rinsing them
with PBS and dried with argon gas.
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Table 7.2: Concentrations used for H2O2 experiments.
Concentration (M)
Lower concentrations 0.01
0.03
0.04
0.05
Higher concentrations 0.1
0.5
1.0
7.2 Lactate Measurements
Lactate measurements were conducted utilising functionalised gold and plat-
inum electrodes. Lactate oxidase was covalently attached to the electrode sur-
faces as explained in Section 6.1.2. The following experiments were conducted.
The protocols for the immobilisation and incubation steps were provided by
the Division of Pathway Medicine.
1. Amperometric measurement of electrodes exposed to 1 hour of incubation
of the lactate oxidase solution on the working electrode.
2. Amperometric measurement of electrodes exposed to overnight incuba-
tion of the lactate oxidase solution of the working electrode.
3. Amperometric measurements after the electrodes were stored for two
days . Incubation was completed before the electrodes were stored.
For all experiments, a potential of 550 mV was applied for platinum and 500 mV
was applied for gold electrodes. A 100 mM lactic acid solution was prepared
for the measurements. The experiments followed the steps below:
1. Electrode preparation
2. Immobilisation (diﬀerent incubation times)
3. Preparation of lactic acid solution
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4. Setting up of the potentiostat
5. Application of 60 µl of PBS
6. Wait for 2 minutes for the system to reaction equilibrium
7. Application of 20 µl of lactic acid solution
8. Measure for 360 seconds
9. Finish measuring
7.3 Results
7.3.1 1st H2O2 Measurements
Amperometric measurements at diﬀerent potentials were conducted to observe
the resulting current responses. Platinum electrodes were measured at 170,
300 and 550 mV and gold electrodes were measured at 500 and 700 mV. The
measurements were performed for 120 seconds in 3% H2O2 solution. The
results of these measurements are shown in Figure 7.1. Each graph represents
one measurement.
The lowest current response was obtained from the negative control (NC) as
expected, followed by the current responses received from the gold electrodes
at 500 mV (green) and 700 mV (dark blue). The current responses obtained
from the platinum electrodes at the potentials 170 mV (blue), 330 mV (orange)
and 550 mV (grey) are higher by one order of magnitude. The visible spikes,
in particular, those for the current response of the platinum electrodes, are
created by bursting bubbles on top of the H2O2 drop placed on the electrode.
Overall, it can be seen that greater currents were obtained using the platinum
electrodes.
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Figure 7.1: Amperometric results of platinum and gold electrodes in H2O2 at dif-
ferent potentials.
7.3.2 2nd H2O2 Measurements
Following that experiment, platinum and gold electrodes were exposed to dif-
ferent H2O2 concentrations. The experiment was set up as followed. The
prepared (gold or platinum) electrode was connected to the potentiostat and
a phosphate buﬀer saline (PBS) was applied to the electrode. After setting
the potential to either 415 or 654 mV, depending on the nature of the metal
deposited, the amperometric measurement commenced for a duration of 360
seconds. An additional 10 µl 3% H2O2 was added to observe the eﬀect of
changing concentrations. The current responses for these measurements are
presented in Figure 7.2. Each graph represents one continuous measurement.
The green and orange graph represent the current received from the gold elec-
trodes at 415 mV and 654 mV respectively. The current response of the plat-
inum electrodes at the same potentials are represented by the red and blue
graph respectively.
The time of H2O2 applications occurred always right before the increase in
119
current for each electrode. Comparing the current responses of the gold and
platinum electrodes at the same potentials, it is again clear that the higher
currents were obtained from the platinum electrode with greater responses,
suggesting that platinum would be an ideal metal for an electrochemical lactate
sensor.
Figure 7.2: Results of amperometric Measurements of H2O2 on gold and Platinum
electrodes at 415 mV and 654 mV.
Additional measurements were conducted in which a 10 % H2O2 solution was
added to a previously applied PBS solution every 20-30 seconds. The point of
application is indicated by red arrows in Figure 7.3 and Figure 7.4. The blue
graph represents the negative control and the green graph shows the current
response of the platinum and gold electrodes at H2O2 application, respectively.
For both responses, there is an increase in current with each application of
H2O2. The current received from the platinum electrode is again higher than
the current received from the gold electrode. Both responses have a sharp
increase in current followed by a decrease, representing the oxidation of H2O2.
The diﬀerence between consecutive responses is observed to lessen with each
application. This is due to the H2O2 concentration on the electrode approach-
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ing the concentration of the solution that is applied.
Figure 7.3: Results of continuous amperometric measurements of platinum elec-
trodes upon subsequent application of H2O2. The red arrows indications the time of
the application of lactate.
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Figure 7.4: Results of continuous amperometric measurements of gold electrodes
upon subsequent application of H2O2. The red arrows indications the time of the
application of lactate.
7.3.3 3rd H2O2 Measurements
Following continuous measurements of the application of consistent concentra-
tions of H2O2 to the electrodes, Figure 7.5 illustrates the result of discontinu-
ous measurement of diﬀering concentrations of H2O2. Each graph represents
one measurement. These measurements were conducted separately and the
electrodes were rinsed with PBS and dried with argon gas in between each
measurement. The duration of each measurement was 180 seconds. The re-
sults shown in Figure 7.5 are based on gold electrodes. As expected, the lowest
concentration results in the lowest current response. When the electrochemical
cell is switched on very high currents (in comparison to the following measured
currents) are observed, due to the formation of the double layer. Therefore,
the ﬁrst 80 seconds are not represented in the graph for resolution purposes.
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Figure 7.5: Amperometric measurement of diﬀerent H2O2 concentrations on gold
electrodes.
From these measurements, calibration curves were generated. A calibration
curve represents the current received with regard to the concentration applied
to the electrode. It shows whether the there is a linear correlation between
the applied concentration and the current received. With this information, the
concentration of a solution can be determined from the current value in the
sensor. Figure 7.6 shows the calibration curve including all concentrations with
the respective current. The correlation was found to be R2 = 0.90. Separate
calibration curves, shown in Figure 7.7 and Figure 7.8, for the lower (0.01 -
0.05M) and higher (0.1 - 1.0 M) concentration ranges, respectively, were also
created. The correlation was still in the same range with R2 = 0.92 and R2 =
0.88, respectively. However, the higher correlation for the lower concentration
may indicate a better sensitivity for lower concentrations. More measurements
are required for more representative results.
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Figure 7.6: Calibration curve of gold electrode H2O2. All measured concentrations.
Figure 7.7: Calibration curve of gold electrode H2O2. (Lower concentrations).
124
Figure 7.8: Calibration curve of gold electrode H2O2. (Higher concentrations).
The same measurement was conducted using platinum electrodes with results
presented in Figure 7.9. Each graph represents one measurement. In gen-
eral, a higher current was obtained in these measurements. The lowest current
was measured from the lowest concentration and the highest from the high-
est concentration. Currents obtained from the following concentrations, 0.01.
0.03, 0.04, 0.05, 0.1, 0.5 M and 1.0 M allowing thereby the setup of a cal-
ibration curves. As an initial calibration curve (Figure 7.10) containing the
respective current values to all concentrations, clearly shows that there are
two linear regions, two separate calibration curves were plotted, one for the
lower concentration (0.01. 0.03, 0.04 and 0.05 M) (Figure 7.11) and one for
the higher concentrations (0.1, 0.5 M and 1.0 M) (Figure 7.12). Then the data
plotted in the separate graphs shows a correlation of R2 = 0.998 and R2 =
0.96. The reason for the diﬀerent linear regions needs to be determined in
additional experiments, by increasing the concentration steps and the number
of measurement.
Overall, greater signals and better signal correlation were obtained from plat-
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Figure 7.9: Current response of platinum electrode at diﬀerent H2O2 concentrations.
inum electrodes Further improvement of the correlation could be achieved by
measuring the volumes with smaller pipettes to achieve more accurate deter-
mination of the concentrations.
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Figure 7.10: Calibration curve of a platinum electrode in H2O2 for all measured
concentrations.
Figure 7.11: Calibration curve of a platinum electrode in H2O2 (lower concentra-
tions).
127
Figure 7.12: Calibration curve of a platinum electrode in H2O2 (higher concentra-
tions).
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7.3.4 Lactate Measurements
In this section, the results of amperometric lactate measurements are pre-
sented. These results include amperometric responses of platinum and gold
electrode where the incubation time of the immobilisation was one hour or
overnight. Furthermore, the strength of the functionalised gold and platinum
electrodes was tested after two days of storing them at 4°C.
Figure 7.13: Amperometric measurements of lactate with immobilised lactate ox-
idase on a gold electrode. The red arrow indications the time of the application of
lactate.
Figure 7.13 shows the amperometric response of one functionalised (one hour
incubation time) gold electrode compared to the negative control which was
an electrode, functionalised with the same solution except for the lactate ox-
idase. The lactic acid solution was added to both electrodes at the same time.
It can be seen from the graph that the current increases (124 - 126.5 seconds)
with the application of a lactate solution (red arrow). It decreases again af-
ter the lactate has been consumed by the lactate oxidase immobilised on the
electrode surface. The noise present in the current response was observed only
with gold electrodes and is also present in the negative control. This baseline
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noise can be subtracted from the main signal in the future to obtain a clearer
response. It may also be possible to reduce the noise applying noise ﬁlters in
the potentiostat.
Figure 7.14: Amperometric measurements of lactate with immobilised lactate oxi-
dase on a platinum electrode. The red arrow indications the time of the application
of lactate.
The same measurement was performed utilising platinum electrodes. The cur-
rent response is at a much larger value, 10 µA, compared to the current re-
sponse on the gold electrodes (0.2 µA). Also visible in Figure 7.14 is that, upon
the application of the lactate solution (red arrow), currents decreases gradually
until no lactate remains to be oxidised, which allows the current return to its
original value.
In order to determine the impact of lactate oxidase solution incubation du-
ration, two gold and three platinum electrodes were prepared and the lactate
oxidase solution was incubated on the electrode overnight. For these measure-
ments new electrodes were used. For the measurement, the potential was set
to 500 mV for the gold electrodes and to 550 mV for the platinum electrodes,
which were obtained from the most recent CV. The resulting currents received
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Figure 7.15: Results of amperometric measurements of lactate using platinum elec-
trodes with immobilised lactate oxidase (overnight (ON) incubation time). The red
arrow indications the time of the application of lactate.
from the platinum electrodes (each graph represents one measurement with one
electrode) are shown in Figure 7.15. The yellow graph represents the negative
control, whereas the other graphs (red, green and blue) represent the current
response of the platinum electrodes exposed to an overnight incubation of the
lactate oxidase solution. The peak currents are between 0.43 - 0.7 µA. The
currents increase instantly upon the lactate application (100 mM) onto the
electrode and decrease gradually afterwards. The current is distinct from the
negative control. The immobilisation with overnight incubation was successful
on platinum electrodes.
These results were compared to the current response obtained from platinum
electrodes that have been exposed to one hour of incubation time. The com-
parison of the two results is presented in Figure 7.16. The current obtained
from the electrodes with one-hour incubation time is much higher (10 µA)
than the current received from the electrodes incubated overnight (0.7 µA).
Therefore, it can be said, that the one-hour incubation time is not only quicker
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Figure 7.16: Overnight incubation time (green, red, bright green) compared to one
hour incubation time (blue) on platinum electrodes. The red arrow indications the
time of the application of lactate.
but also more successful compared to the current response from the overnight
incubation time.
The same measurements were conducted with the new gold electrodes. The
gold electrodes were prepared and exposed to an overnight incubation of the
lactate oxidase solution. For the measurement, a 100 mM lactate solution was
applied to the electrode and the current response after a potential of 500 mV
was applied.
The resulting currents are presented in Figure 7.17. The yellow graph repre-
sents the negative control and the other two (grey and orange) are the current
response of the electrodes exposed to an overnight incubation. No typical am-
perometric response was observed from the measurement of the gold electrodes.
In addition, the negative control is higher than the positives which are indica-
tive of contamination of the negative control electrode. Furthermore, upon
the application of the lactate solution, the response is more negative than the
baseline. The negative control also exhibits a sudden decrease in current after
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Figure 7.17: Results of amperometric measurements of lactate using gold electrodes
with immobilised lactate oxidase (One hour incubation time). The red arrow indica-
tions the time of the application of lactate.
the application of the lactate solution. The overall currents obtained from all
the measurements are between 0.025 and 0.05 µA; low compared to the current
(0.2 µA) received from the lactate measurements presented in Figure 7.13.
These results lead to the conclusion that the immobilization of lactate oxidase
onto gold electrodes overnight was not successful, which says that the high
impedance obtained from the EIS measurements in Section 6.3.3 was due to
the reagents accumulating on the surface of the working electrode.
The electrodes that were exposed to a one-hour incubation time were stored
in PBS for two days after the measurements. The current response to lactate
was measured again after the two days. The results for gold and platinum
electrodes are shown in Figure 7.18 and Figure 7.19 respectively. In general,
as also observed in the other measurement, platinum exhibits a higher current
overall (10 µA) compared to gold (0.2 µA). Both electrodes, however, show a
much smaller or no signal upon lactate application after two days of storage.
Further improvements for the storage capabilities are required to develop a
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Figure 7.18: Amperometric measurements of gold electrodes after 1 hour incubation
and then after 2 days in PBS. The red arrow indications the time of the application
of lactate.
usable lactate sensor. This could be achieved by adding a layer of naﬁon as
introduced in Section 4.3.1.
From these measurements, it can be concluded that no enzyme activity was
found on the gold electrode after two days, but a current response was received
from the platinum electrode after two days although it was lower than the
current response measured on the same day of immobilisation. This is shown
in Figure 7.19.
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Figure 7.19: Amperometric measurements with platinum electrodes after 1 hour
incubation and then after 2 days in PBS. The red arrow indications the time of the
application of lactate.
7.4 Conclusions
In conclusion, higher currents were obtained from platinum electrodes dur-
ing H2O2 and lactate measurements. One hour of incubation provided better
amperometric results for both electrodes.
The amperometric response of the gold electrode exposed to an overnight incu-
bation was indicative of inactive enzymes. After storing the electrodes in PBS
for two days the current response from the platinum electrode was lower than
the current received on the same day. However, this current was still higher
than the current obtained from the measurements of the gold electrode on the
same day of immobilisation.
Based on the results of the initial measurements, platinum is most likely to
be more successful for the development of lactate sensor for foetal monitoring
during birth.
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8 Conclusions and future work
In this chapter, the ﬁndings of the previous chapters are summarised and
overall conclusions are drawn. Additionally, future work is suggested to develop
a new foetal monitoring device.
8.1 Conclusions
Although foetal monitoring has improved, there is a common agreement be-
tween professionals that more research work into new monitoring techniques
needs to be done, as current methods are laborious, prone to errors and inva-
sive [62, 63, 64]. The results and conclusions of this research are based on the
aims and objectives laid out in section Section 1.3.
Firstly, the most appropriate measurand had to be identiﬁed and selected for
further development of a novel foetal monitoring system. Lactate showed the
most potential as a potential alternative measurand for intrapartum foetal
monitoring, due to its ability to distinguish between diﬀerent types of acidosis.
In current clinical settings it is being measured alongside the pH value when
performing foetal scalp blood sampling. It is however not used for decision-
making yet.
Additionally, the diﬀerent biosensor characteristics, such as sampling, recog-
nition, immobilisation and transduction were reviewed for the ideal ﬁt for a
intrapartum foetal lactate sensor. Clinical speciﬁcations were provided by Dr.
Fiona Denison, and Dr. Sarah Stock, expert clinicians dealing regularly with
complex labours. Based on these speciﬁcations and after having reviewed the
medical rationale for monitoring baby's blood during labour, a technical liter-
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ature review was carried out in Chapter 4 on biosensing with a focus on lactate
sensing.
For sampling, bioﬂuid microneedles were identiﬁed to serve as a basis for the
new sensor device due to its minimally invasive nature. The transduction
method of amperometry was found to be the most common and was useful
for this application since more than 90% of the publications reviewed for lac-
tate sensing were based on amperometric measurements. Furthermore, lactate
oxidase was identiﬁed as a recognition element because it does not require a
co-enzyme as lactate dehydrogenase does. The means of immobilising the en-
zyme were explored and covalent bonding and crosslinking were found to hold
the greatest potential because both provide a strong bond with the electrode
surface to prevent leaching of the enzyme. The literature demonstrated that
gold and platinum electrodes delivered reliable and sensitive results for lactate
sensing, with many examples of these materials being successfully applied.
Based on the results of the technical literature review the new prototype sensor
was designed, manufactured and tested based on the following three steps:
1. Electrode Fabrication
2. Immobilisation
3. Amperometric Measurements
For the electrode fabrication described in Section 5.4, commercial electrodes
from the company DropSens were purchased to perform basic electrochemical
measurements. The electrochemical surface area was found to be almost twice
as large as the geometrical surface area. Microneedles were also purchased
from MicroPoint and their compatibility with the electron beam evaporation
process was proven. Using an improved masking method a three-electrode
system was deposited onto a dummy substrate made from PMMA utilising
the electron beam evaporator. A prototype sensor was successfully assembled
using an adapter fabricated from standard FR4 copper printed circuit board.
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The fourth aim of this project was the characterisation of the immobilisa-
tion protocols on diﬀerent electrode surfaces. Two immobilisation methods,
covalent bonding and crosslinking, were tested in Chapter 6. Initial mea-
surements using cyclic voltammetry and amperometry showed that covalent
bonding seems to hold greater potential for lactate oxidase immobilisation, as
a greater current signal was obtained. With the focus on covalent bonding,
the crosslinking reagents DTT and TCEP, which were adapted from standard
immobilisation protocols, were compared and the results show that the immo-
bilisation was successful with DTT but not with TCEP. Diﬀerent incubation
times of the enzyme solution on the electrode surface were tested and charac-
terised using electrochemical impedance spectroscopy with the result that the
one-hour incubation time provided larger impedance values.
Subsequent amperometric measurements also investigated diﬀerent incubation
times on the enzyme solution of the electrodes surface were explored and it was
found that a one hour incubation time is suﬃcient. Furthermore, it was found,
when testing electrode after storing them for two days, that the enzyme ac-
tivity decreases over time. In addition, two diﬀerent electrode materials, gold,
and platinum, were compared throughout the above experiments.
Platinum electrodes provided a better a greater amperometric response and
the immobilisation was more often successful. Based on the results obtained
from this experiment, platinum is most likely to provide a good basis for the
electrochemical lactate sensor.
The ﬁfth aim, which was to characterise the performance of the resulting sys-
tem, was achieved partially. Overall, several key steps have been taken towards
the development of a lactate sensor for foetal monitoring, demonstrating that
using platinum electrodes and covalent bonding based immobilisation using
DTT give promising results with amperometric lactate measurements. Fur-
thermore, a proof-of-principle of the manufacturing steps of the proposed sys-
tem has been shown, demonstrating the possibility to utilise microneedles in
this application. However, further, development is required to integrate these
two advances.
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This work provides background research and reviews in the ﬁeld of lactate
sensing and intrapartum foetal monitoring in order to improve current foetal
monitoring during birth, which is laborious, invasive and prone to errors. By
further developing the work carried out in this project as laid out in the fol-
lowing section, it may be possible to continuously monitor babies during birth.
This may provide clearer and real-time data for a safer delivery of the baby.
8.2 Future Work
As this work presented preliminary results and proof of concept towards to the
development of lactate sensor for foetal monitoring during birth, further work
is required to establish a new sensor fulﬁlling the clinical requirements. There
are three main courses for further work:
1. Development of immobilisation protocol
2. Fabrication of a microneedle electrode
3. Microneedle array fabrication.
Firstly, the covalent bonding immobilisation protocol requires further optimisa-
tion and characterisation utilising commercial platinum electrodes. Following
that, calibration curves can be obtained in the required lactate concentration
range (2 - 14 mM). The optimised immobilisation results on the commercial
electrodes can be further characterised determining their sensitivity, selectiv-
ity, detection limit and response time. During the course of these experiments,
the repeatability of the results can be shown. Additionally, measurements over
a longer duration, such as 12 hours, have to be taken to ensure stable lactate
detection over the length of labour. Finally, the functionalised commercial
electrodes should be tested regarding their storage stability, storing them for
a longer period and testing the enzyme activity regularly.
Secondly, the electrode fabrication can be optimised further and the repeata-
bility should be ensured. This should be done ﬁrst on the PMMA sheets. It
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might be sensible to explore other metal deposition methods such as sputtering
which exhibits less heat generation during the deposition process. The sen-
sor fabricated on the PMMA sheet can be characterised electrochemically as
described above. Once optimised, the fabrication protocol can be transferred
to the microneedle array which then again should be electrochemically char-
acterised. Amperometric measurements conducted utilising the commercial
electrodes should be conducted on the fabricated microneedle electrodes for
comparison.
Once a working lactate sensor has been developed successfully the measure-
ments should be conducted using blood. Additionally, methods for preventing
potential leaching should be explored. Possible materials such as naﬁon have
been mentioned in the literature review [126]. In addition to the development
of the lactate sensor utilising commercial microneedle arrays, possibilities for
the fabrication of microneedle arrays can be explored. Common fabrication
methods are laser micromachining [104], UV photolithography [105], micro-
molding [106], drawing lithography in combination with electroplating [116].
In conclusion, the literature review has shown that electrochemical in vivo lac-
tate sensing has been achieved. Further improvement of the immobilisation
process will most likely lead to a successful development of a lactate sensor
based on commercial electrodes.
However, it remains to be proven, whether combining the electrochemical lac-
tate sensor with microneedle arrays provide the ideal solution for foetal moni-
toring during birth.
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